{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "0a120d46",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "626ad45c",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv(\"dfAllData.csv\", index_col=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "851fcd62",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Columns in dfAllData.csv:\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "Index(['Study Title', 'Study URL', 'Acronym', 'Study Status', 'Brief Summary',\n",
       "       'Study Results', 'Conditions', 'Interventions',\n",
       "       'Primary Outcome Measures', 'Secondary Outcome Measures',\n",
       "       'Other Outcome Measures', 'Sponsor', 'Collaborators', 'Sex', 'Age',\n",
       "       'Phases', 'Enrollment', 'Funder Type', 'Study Type', 'Study Design',\n",
       "       'Other IDs', 'Start Date', 'Primary Completion Date', 'Completion Date',\n",
       "       'First Posted', 'Results First Posted', 'Last Update Posted',\n",
       "       'Locations', 'Study Documents', 'Target'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns\n",
    "\n",
    "print(\"Columns in dfAllData.csv:\")\n",
    "\n",
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "ffe1ca0d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(6968, 30)"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5a994d34",
   "metadata": {},
   "outputs": [],
   "source": [
    "selected_columns = [\n",
    "    'Study Title', \n",
    "    'Brief Summary', \n",
    "    'Conditions', \n",
    "    'Interventions', \n",
    "    'Primary Outcome Measures', \n",
    "    'Sponsor', \n",
    "    'Collaborators', \n",
    "    'Sex', \n",
    "    'Age', \n",
    "    'Phases', \n",
    "    'Enrollment', \n",
    "    'Funder Type', \n",
    "    'Study Type', \n",
    "    'Study Design',\n",
    "    'Target'  \n",
    "]\n",
    "\n",
    "df_selected = df[selected_columns].fillna('Unknown')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "c24e3e6e",
   "metadata": {},
   "outputs": [],
   "source": [
    "def create_prompt(row):\n",
    "    prompt = (\n",
    "        f\"Study Title: {row['Study Title']}\\n\"\n",
    "        f\"Brief Summary: {row['Brief Summary']}\\n\"\n",
    "        f\"Condition: {row['Conditions']}\\n\"\n",
    "        f\"Intervention: {row['Interventions']}\\n\"\n",
    "        f\"Primary Outcome Measure: {row['Primary Outcome Measures']}\\n\"\n",
    "        f\"Sponsor: {row['Sponsor']}\\n\"\n",
    "        f\"Collaborators: {row['Collaborators']}\\n\"\n",
    "        f\"Sex: {row['Sex']}\\n\"\n",
    "        f\"Age: {row['Age']}\\n\"\n",
    "        f\"Phase: {row['Phases']}\\n\"\n",
    "        f\"Enrollment: {row['Enrollment']}\\n\"\n",
    "        f\"Funder Type: {row['Funder Type']}\\n\"\n",
    "        f\"Study Type: {row['Study Type']}\\n\"\n",
    "        f\"Study Design: {row['Study Design']}\\n\"\n",
    "        \"\\nBased on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\"\n",
    "    )\n",
    "    return prompt\n",
    "\n",
    "# Apply\n",
    "df_selected['prompt'] = df_selected.apply(create_prompt, axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "b33a6a9f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Study Title: Novel Biomarker for Development of T2D\n",
      "Brief Summary: The investigators wants to determine if 11β-HSD1 activity will be positively associated, and 5α-reductase activity negatively associated, with (a) degree of insulin resistance defined by the homeostatic model assessment of insulin resistance index (HOMA-IR) and (b) worsening glycemic control defined by higher HbA1c and impaired fasting glucose in a group of obese children and young adults with or without type 2 diabetes compared to lean children and young adults without diabetes. The investigators also want to identify key metabolic signatures associated with diabetes using metabolomic profiling.\n",
      "Condition: Diabetes Type II\n",
      "Intervention: Unknown\n",
      "Primary Outcome Measure: Relationship between 11β-HSD1 and 5α-reductase activity, and measures of insulin resistance, To assess the relationship between 11β-HSD1 and 5α-reductase activity, and measures of insulin resistance in a cohort of obese children with varying degrees of insulin resistance and glucose intolerance, One year|Gender and pubertal status, Investigate the role of gender and pubertal status on 11β-HSD1 and 5α-reductase activity, One year|Compare 11β-HSD1 activity and 5α-reductase activity among obese adolescents with T2D, obese adolescents without T2D and normal weight controls, The investigators hypothesize that obese adolescents with T2D will have the highest levels of 11β-HSD1 activity followed by the obese adolescents with insulin resistance, followed by obese subjects with normal insulin sensitivity. Normal weight control group will have the lowest levels., One year\n",
      "Sponsor: Duke University\n",
      "Collaborators: Children's Miracle Network|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\n",
      "Sex: ALL\n",
      "Age: CHILD, ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 202.0\n",
      "Funder Type: OTHER\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\karan\\AppData\\Local\\Temp\\ipykernel_11024\\1960260464.py:1: FutureWarning: Series.__getitem__ treating keys as positions is deprecated. In a future version, integer keys will always be treated as labels (consistent with DataFrame behavior). To access a value by position, use `ser.iloc[pos]`\n",
      "  print(df_selected[\"prompt\"][0])\n"
     ]
    }
   ],
   "source": [
    "print(df_selected[\"prompt\"][0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "bbbf9268",
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests\n",
    "import time\n",
    "\n",
    "GROQ_API_KEY = '##'\n",
    "\n",
    "\n",
    "def query_groq(prompt):\n",
    "    url = \"https://api.groq.com/openai/v1/chat/completions\"\n",
    "    headers = {\n",
    "        \"Authorization\": f\"Bearer {GROQ_API_KEY}\",\n",
    "        \"Content-Type\": \"application/json\"\n",
    "    }\n",
    "    data = {\n",
    "        \"model\": \"llama3-8b-8192\",  \n",
    "        \"messages\": [{\"role\": \"user\", \"content\": prompt}],\n",
    "        \"temperature\": 0.2,  \n",
    "        \"max_tokens\": 50     \n",
    "    }\n",
    "    response = requests.post(url, headers=headers, json=data)\n",
    "    if response.status_code == 200:\n",
    "        result = response.json()\n",
    "        reply = result['choices'][0]['message']['content']\n",
    "        return reply.strip()\n",
    "    else:\n",
    "        print(f\"Error {response.status_code}: {response.text}\")\n",
    "        return None\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "eadcb30b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus\n",
      "Brief Summary: This trial is conducted globally. The aim of this trial is to investigate efficacy and safety of oral Semaglutide versus Liraglutide and versus Placebo in Subjects with Type 2 Diabetes Mellitus.\n",
      "Condition: Diabetes|Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: semaglutide|DRUG: liraglutide|DRUG: placebo\n",
      "Primary Outcome Measure: Change in HbA1c (Week 26), Change from baseline (week 0) in glycosylated haemoglobin (HbA1c) was evaluated at week 26. The endpoint was evaluated based on the data from the in-trial observation period, which was the time period from when a participant was randomised until the final scheduled visit, including any period after initiation of rescue medication and/or premature discontinuation of trial product. The endpoint was also evaluated based on the data from the on-treatment without rescue medication observation period, which was the time period when a participant was on treatment with trial product, excluding any period after initiation of rescue medication and/or premature trial product discontinuation., Week 0, week 26\n",
      "Sponsor: Novo Nordisk A/S\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 711.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Evaluate the Safety and Efficacy of Sinocare CGM System Regarding Real Time Glucose Level Monitoring\n",
      "Brief Summary: From Jan 2022 to June 2022, 120 subjects (22-75 years of age, mean ±standard deviation \\[SD\\] of 53.20 ±14.49 years) with type 1 or type 2 diabetes participated in the study in P.R. China. Subjects wore two sensors in the abdomen which were paired with smart devices running a glucose monitoring mobile application (i3/H3 CGM APP). Subjects were asked to undergo one in-clinic visit (on one of the study days 2, 7-9, or 15) for 7-hour long YSI frequent sampling test (FST) periods, where intravenous (IV) blood samples were drawn every 15 min and analyzed using the YSI 2300 STAT Plus Glucose \\& Lactate Analyzer (Yellow Springs Instrument, YSI Life Sciences, Yellow Springs, OH).\n",
      "Condition: Type 1 or Type 2 Diabetes\n",
      "Intervention: Unknown\n",
      "Primary Outcome Measure: overall mean absolute relative difference (MARD), 8 or 15 days\n",
      "Sponsor: Sinocare\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 120.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.\n",
      "Brief Summary: Fluid management study in patients with type 2 diabetes and autonomic neuropathy.\n",
      "Condition: Neuropathy, Diabetic\n",
      "Intervention: DRUG: rosiglitazone\n",
      "Primary Outcome Measure: Change in transcapillary escape rate of L125 albumin following 16 weeks treatment\n",
      "Sponsor: GlaxoSmithKline\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 36.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections\n",
      "Brief Summary: Liraglutide, a GLP-1-analogue has been shown to be an effective treatment option in patients on oral anti-diabetes therapy with beneficial effects on both glycaemic control and weight. However, to date there are no clinical trials of liraglutide added to insulin therapy, a population of patients generally having worse glycaemic control and weight gain. In clinical guidelines, use of multiple daily insulin injections (MDI) is usually the final therapeutic option for type 2 diabetic patients.\n",
      "\n",
      "The primary study aim is to evaluate whether the addition of liraglutide, compared to placebo, reduces the HbA1c level for overweight and obese type 2 diabetes patients with inadequate glycaemic control treated with multiple daily insulin injections (MDI). MDI is defined as treatment with any basal insulin combined with separate meal time insulin injections before the main meals, i.e. an insulin regimen with premixed insulin is not considered as MDI.\n",
      "\n",
      "The planned study duration is 24 weeks and includes 120 patients at 15 centers in Sweden.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: DRUG: Liraglutide|DRUG: Placebo\n",
      "Primary Outcome Measure: Change in HbA1c from baseline to week 24., Baseline, week 24\n",
      "Sponsor: Vastra Gotaland Region\n",
      "Collaborators: Novo Nordisk A/S\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE2\n",
      "Enrollment: 124.0\n",
      "Funder Type: OTHER_GOV\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes\n",
      "Brief Summary: This study is conducted in Africa. The aim of this study is to assess the safety and efficacy of Levemir® treatment for insulin naive patients with type 2 diabetes under normal clinical practice conditions in Algeria.\n",
      "Condition: Diabetes|Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: insulin detemir\n",
      "Primary Outcome Measure: Assessment the incidence of the Serious Adverse Events including the major Hypoglycaemia., During study\n",
      "Sponsor: Novo Nordisk A/S\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 1976.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Description of Drug Utilization and Assessment of Impact of Saxagliptin on Health Status of Patients With Type 2 Diabetes in France\n",
      "Brief Summary: The purpose of this study is to respond to The French Health Authority which has requested BMS France and Astra Zeneca (AZ) France to set-up a long-term cohort study in a representative sample of French Type 2 Diabetes mellitus (T2D) patients treated with Saxagliptin to generate real world data on drug utilization, joint population, non comparative effectiveness and safety\n",
      "Condition: Type 2 Diabetes Mellitus (T2D)\n",
      "Intervention: DRUG: Saxagliptin\n",
      "Primary Outcome Measure: Evolution of Glycated hemoglobin (HbA1c) level, weight and the onset of hypoglycemic over time (2 years) for patients treated with Saxagliptin, HbA1c level \\<7% at Y2, weight and assessment of hypoglycaemic events after a 2-year exposure to Saxagliptin, 24 months|Joint population of Saxagliptin based on socio-demographic data, medical history, disease history, comorbidities including renal, hepatic and cardiac functions, HbA1c level at treatment initiation), One year (average)|Utilization of Saxagliptin by General practitioners (GPs) and diabetologists in France (based on indication, initial dosage and adjustments, co-prescriptions, glycemic monitoring), During the treatment (Up to 2 years)|Retention rate of Saxagliptin and to describe discontinuation rate and reasons, At 2 years\n",
      "Sponsor: AstraZeneca\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 1000.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Dietary Approaches to Stop Hypertension for Diabetes\n",
      "Brief Summary: The objective of the DASH4D trial is to determine the effects, alone and combined, of (a) the DASH4D diet (a DASH-style diet modified for people with diabetes) vs. comparison diet that is typical of what many Americans with diabetes eat and (b) lower sodium intake vs. higher sodium intake on blood pressure (BP). The core design is a single-site, 4-period, crossover feeding study with 5-week periods. Participants are fed each of four isocaloric diets, presented in random order. The primary contrast of interest is DASH4D diet with lower sodium vs. comparison diet with higher sodium.\n",
      "Condition: Diabetes Mellitus, Type 2|Diabetes|Diabetes type2|Type2 Diabetes|Type 2 Diabetes|Type II Diabetes|Hypertension|High Blood Pressure\n",
      "Intervention: OTHER: DASH4D diet|OTHER: comparison diet|OTHER: higher sodium|OTHER: lower sodium\n",
      "Primary Outcome Measure: Systolic blood pressure (SBP), After the participant has rested quietly in the seated position for at least 5 minutes, blood pressure will be measured in triplicate, using an Omron device, with each reading separated by 30 seconds, and the average of the three readings (in mmHg) will also be recorded. Blood pressure will be measured on five separate occasions during the last 2 weeks of the feeding period, and the mean systolic blood pressure from these five blood pressures (15 total readings) will be used as the primary outcome., At the end of 5-week feeding period\n",
      "Sponsor: Johns Hopkins University\n",
      "Collaborators: Beth Israel Deaconess Medical Center|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Sheikh Khalifa Stroke Institute\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 105.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: SGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular Risk\n",
      "Brief Summary: Patients with type 2 diabetes (T2 DM) have a markedly increased risk of heart disease and it is estimated that, in the danish population, up 80% percent of patients with type 2 diabetes die from heart disease.\n",
      "\n",
      "The sodium glucose cotransport-2 (SGLT-2) inhibitors were developed as an anti-diabetic therapy reducing blood glucose and weight by decreasing glucose reabsorption in the kidneys, leading to glucose excretion via the urine. However, in 2015 the EMPA-REG study showed that treatment with the SGLT-2 inhibitor empagliflozin significantly reduced the cardiovascular mortality and risk of admission under the diagnosis of heart failure in a population of patients with type 2 diabetes in addition to other risk factors for heart disease. The mechanism behind this surprising result is unknown and warrants further study.\n",
      "\n",
      "The primary hypothesis of the present study is that treatment with empagliflozin improves the function and blood supply of the heart muscle cells in patients with type 2 diabetes and high risk of heart disease. The investigators will test this hypothesis by enrolling 92 participants with type 2 diabetes and other risk factors for heart disease, and treating them with either empagliflozin or a placebo. During the study period the investigators will monitor the effects of the treatment with various techniques such as heart scans using CT and ultrasound, measurements of the fluid pressures in the heart chambers, body composition measurements and a variety of relevant blood test.\n",
      "Condition: Type2 Diabetes Mellitus\n",
      "Intervention: DRUG: Empagliflozin|DRUG: Placebo Oral Tablet\n",
      "Primary Outcome Measure: Rb-82 PET, Between group difference in the change in myocardial flow reserve (MFR) by Rb-82 PET. Measured as change in global perfusion from rest to adenosine-induced stress., 13 weeks|Invasive hemodynamics, Substudy, performed on 38 participants from the main group. Using right heart catheterisation to measure between group difference in the change in pulmonary capillary weight pressure (PCWP) at 25 watts (supine bicycle ergometer), 13 weeks\n",
      "Sponsor: Caroline M Kistorp\n",
      "Collaborators: Danish Heart Foundation|Herlev and Gentofte Hospital|Rigshospitalet, Denmark\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 92.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Sleep Loss and Energy Metabolism in People With Family History of Type 2 Diabetes.\n",
      "Brief Summary: The use of energy from food changes when people sleep. However, it is still not known if differences in the amount of nighttime sleep have an effect on the amount of energy that people who have a relative with type 2 diabetes (parent, sibling, or grandparent) use to perform their daily activities. This study is being done to test the hypothesis that the daily use of energy in people who have a history of type 2 diabetes in their family will be different after they have slept short hours for 16 days in comparison to when they have slept longer hours for 16 days.\n",
      "Condition: Sleep|Sleep Deprivation|Insulin Resistance|Type 2 Diabetes\n",
      "Intervention: OTHER: 5.5-hour bedtime|OTHER: 8.5-hour bedtime\n",
      "Primary Outcome Measure: Total energy expenditure, during each bedtime intervention\n",
      "Sponsor: University of Chicago\n",
      "Collaborators: National Heart, Lung, and Blood Institute (NHLBI)\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 12.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Effect of Moringa Oleifera Leaves on Glycemic Control of Women With Type 2 Diabetes\n",
      "Brief Summary: The objective of this clinical trial was to understand whether supplementation of Moringa oleifera leaf powder improved glycemic management in Sahrawi women with type 2 diabetes living in refugee camps. The main question sought to be answered was:\n",
      "\n",
      "- Does daily supplementation of Moringa oleifera leaf powder, in addition to oral hypoglycemic therapy, improve glycosylated hemoglobin and fasting blood glucose?\n",
      "\n",
      "Researchers compared Moringa supplementation with no Moringa consumption to see if Moringa oleifera worked to improve glycemic control.\n",
      "\n",
      "Participants had to:\n",
      "\n",
      "* Take Moringa oleifera leaves daily or abstain from consuming Moringa for 3 months.\n",
      "* Consistently take prescribed oral hypoglycemic agents\n",
      "* Undergo clinical examinations and measurement of biochemical, metabolic and body composition parameters at the time of recruitment and at the end of the study.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DIETARY_SUPPLEMENT: Supplementation of Moringa oleifera leaf powder\n",
      "Primary Outcome Measure: Glycosylated hemoglobin (HbA1c), Glycosylated hemoglobin was measured at recruitment and at the end of the study (three months)|Fasting glucose, Fasting glucose was measured at recruitment and at the end of the study (three months)\n",
      "Sponsor: University of Milan\n",
      "Collaborators: Unknown\n",
      "Sex: FEMALE\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 52.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Influence of Regular Exercise and Detraining on Metabolic and Emotional Parameters in Diabetic Individuals\n",
      "Brief Summary: This quasi-experimental study aim to evaluate the effect of moderate aerobic exercise on glucose and lipid metabolism as well as the scales of anxiety and depression and levels of salivary cortisol in women with type 2 diabetes.\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: OTHER: Exercise\n",
      "Primary Outcome Measure: Glucose levels, After practicing the exercise for 3 months, patients were submitted to a new collection of blood for Glucose test., 3 months\n",
      "Sponsor: University of Campinas, Brazil\n",
      "Collaborators: Unknown\n",
      "Sex: FEMALE\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 12.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: \n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Complement and Cardiovascular Risk in Adolescents\n",
      "Brief Summary: This study evaluates how genetic variations in complement, a part of the immune system, affect cardiovascular risk in adolescents.\n",
      "Condition: Cardiovascular Disease|Type 2 Diabetes\n",
      "Intervention: Unknown\n",
      "Primary Outcome Measure: Complement C3 Genotype, Genetic C3F genotype allele presence, Baseline|C4 Copy Number, C4A or C4B gene copy numbers, Baseline\n",
      "Sponsor: Ohio State University\n",
      "Collaborators: American Heart Association\n",
      "Sex: ALL\n",
      "Age: CHILD, ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 77.0\n",
      "Funder Type: OTHER\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Onduo Virtual Diabetes Clinic Study\n",
      "Brief Summary: This is a prospective, single arm study designed to evaluate the change in hemoglobin A1c after 4 months of participation in the Onduo Virtual Diabetes Clinic (VDC) in individuals with Type 2 diabetes and suboptimal glycemic control.\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: DEVICE: Onduo App\n",
      "Primary Outcome Measure: Mean Change in Hemoglobin A1c, Mean change in hemoglobin A1c from enrollment to 4 months, 4 Months\n",
      "Sponsor: Verily Life Sciences LLC\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 60.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378\n",
      "Brief Summary: A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-378\n",
      "Condition: Type II Diabetes\n",
      "Intervention: DRUG: CKD-378, QD, PO Drug: D745, D150, QD, PO\n",
      "Primary Outcome Measure: 1. AUCt of CKD-378: Area under the concentration-time curve time zero to time, Pre-dose(0 hour) to 48 hours|2. Cmax of CKD-378: Maximum plasma concentration of the drug, Pre-dose(0 hour) to 48 hours\n",
      "Sponsor: Chong Kun Dang Pharmaceutical\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 24.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Adiponectin in Obese Women With T2DN and Effects by RAS Blocker\n",
      "Brief Summary: Insulin resistance typically characterizes type 2 diabetes (T2DM) and prediabetic states and is the prominent feature of the metabolic syndrome.Adiponectin plays an important part in glucose metabolism,insulin resistance, the deterioration of renal function.we hypothesize there is a difference serum adiponectin levels between obese and non-obese women with type 2 diabetic nephropathy. Furthermore, these two groups would respond difference to the RAs blocker(Losartan).\n",
      "Condition: Obese|Type 2 Diabetes|Diabetic Nephropathy|Glucose Metabolism|Angiotensin II Type 1 Receptor Blockers\n",
      "Intervention: DRUG: losartan\n",
      "Primary Outcome Measure: GFR, HbA1c and the adiponectin concentration., 6 month\n",
      "Sponsor: Shanghai Jiao Tong University School of Medicine\n",
      "Collaborators: Unknown\n",
      "Sex: FEMALE\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 80.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: |Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes\n",
      "Brief Summary: The objective of the current study is to investigate the efficacy, safety and tolerability of linagliptin (5 mg / once daily) compared to placebo given for 24 weeks as add-on therapy to stable treatment in elderly patients with T2DM with insufficient glycaemic control\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: linagliptin|DRUG: placebo\n",
      "Primary Outcome Measure: HbA1c Change From Baseline to Week 24, HbA1c is measured as a percentage. Thus, this change from baseline reflects the Week 24 HbA1c percent minus the baseline HbA1c percent. Means are treatment adjusted for baseline HbA1c and prior use of insulin., Baseline and week 24\n",
      "Sponsor: Boehringer Ingelheim\n",
      "Collaborators: Eli Lilly and Company\n",
      "Sex: ALL\n",
      "Age: OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 241.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events\n",
      "Brief Summary: This study is being carried out to determine the effect of dapagliflozin on cardiovacular outcomes when added to current background therapy in patients with type 2 diabetes with either established cardiovacular disease or cardiovascular risk factors.\n",
      "Condition: Diabetes Mellitus, Non-Insulin-Dependent|High Risk for Cardiovascular Event\n",
      "Intervention: DRUG: Dapagliflozin 10 mg|DRUG: Placebo tablet\n",
      "Primary Outcome Measure: Subjects Included in the Composite Endpoint of CV Death, MI or Ischemic Stroke, Safety and co-primary efficacy, up to 5.2 years|Subjects Included in the Composite Endpoint of CV Death or Hospitalization Due to Heart Failure., Co-primary efficacy, up to 5.2 years\n",
      "Sponsor: AstraZeneca\n",
      "Collaborators: Bristol-Myers Squibb|The TIMI Study Group|Hadassah Medical Organization\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 17190.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes\n",
      "Brief Summary: This trial is conducted in Europe.\n",
      "\n",
      "The aim of this trial is to investigate the efficacy and safety of an intensified treatment regimen with preprandial insulin aspart and insulin detemir once or twice daily to a more convenient regimen with biphasic insulin aspart 30 twice daily on blood glucose control in subjects with type 2 diabetes.\n",
      "Condition: Diabetes|Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: insulin detemir|DRUG: insulin aspart|DEVICE: biphasic insulin aspart\n",
      "Primary Outcome Measure: HbA1c, after 6 months of treatment\n",
      "Sponsor: Novo Nordisk A/S\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 719.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes\n",
      "Brief Summary: This study is being conducted to assess the overall safety and tolerability of a single intravenous infusion of three doses of Mesenchymal Precursor Cells versus Placebo in subjects with Type 2 Diabetes inadequately controlled on Metformin.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DRUG: Mesenchymal Precursor Cells (MPCs)|DRUG: Mesenchymal Precursor Cells (MPCs)|DRUG: Mesenchymal Precursor Cells (MPCs)\n",
      "Primary Outcome Measure: Primary objective of the study is to assess the safety and tolerability of MPC therapy, Outcomes include the measurement of the following safety parameters:\n",
      "\n",
      "* Adverse events and serious adverse events(including hypoglycemia)\n",
      "* Vital signs (BP, HR, RR, O2 saturation)\n",
      "* Physical examinations\n",
      "* Results of clinical laboratory tests (hematology, biochemistry, and urinalysis, flow cytometry Class I and Class II PRA % with specificity, antibovine and antimurine antibody analysis)\n",
      "* Pulmonary function test\n",
      "* Electrocardiograms\n",
      "* Chest X-ray\n",
      "* Fundus oculi examination, 116 Weeks\n",
      "Sponsor: Mesoblast, Ltd.\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1|PHASE2\n",
      "Enrollment: 61.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes\n",
      "Brief Summary: The purpose of this study is to determine if albiglutide is safe and effective in the treatment of type 2 diabetes.\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: BIOLOGICAL: albiglutide|DRUG: sitagliptin|DRUG: glimepiride|DRUG: metformin|BIOLOGICAL: placebo albiglutide|DRUG: placebo sitagliptin|DRUG: placebo glimepiride\n",
      "Primary Outcome Measure: Change From Baseline (BL) in Glycosylated Hemoglobin (HbA1c) at Week 104, HbA1c is a form of hemoglobin that is measured primarily to identify the average plasma glucose concentration over a 2- to 3-month period. The BL HbA1c value is defined as the last non-missing value before the start of treatment. Change from BL was calculated as the value at Week 104 minus the value at BL. Based on analysis of covariance (ANCOVA): change = treatment + BL HbA1c + prior myocardial infarction history + age category + region. Difference of least squares means (albiglutide - placebo, albiglutide - sitagliptin, albiglutide - glimepiride) is from the ANCOVA model. The last observation carried forward (LOCF) method was used to impute missing post-Baseline HbA1c values; the last non-missing post-BL on-treatment measurement was used to impute the missing measurement. HbA1c values obtained after hyperglycemic rescue were treated as missing and were replaced with pre-rescue values., Baseline and Week 104\n",
      "Sponsor: GlaxoSmithKline\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 1049.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Thyroid Function and Diabetes Complications\n",
      "Brief Summary: The purpose of this study is to investigate the potential association between thyroid function and diabetes complications in the elderly subjects with type 2 diabetes mellitus (T2DM).\n",
      "Condition: Diabetes|Thyroid Disease\n",
      "Intervention: OTHER: no intervention\n",
      "Primary Outcome Measure: Diabetic retinopathy which is diagnosed by the measurement of fundus fluorescein angiography. (Diabetic retinopathy is clinically graded based on the international clinical diabetic retinopathy severity scales.), Day One\n",
      "Sponsor: Nanjing First Hospital, Nanjing Medical University\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 260.0\n",
      "Funder Type: OTHER\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D\n",
      "Brief Summary: To determine the effect of the method of hyperglycemic management on pro- thrombotic potential in diabetic subjects.\n",
      "Condition: Cardiovascular Diseases|Heart Diseases|Diabetes Mellitus, Non-insulin Dependent|Coronary Disease|Thrombosis|Diabetes Mellitus\n",
      "Intervention: Unknown\n",
      "Primary Outcome Measure: Unknown\n",
      "Sponsor: National Heart, Lung, and Blood Institute (NHLBI)\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: CHILD, ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: Unknown\n",
      "Funder Type: NIH\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: My Diabetes Care: A Scalability and Usability Study\n",
      "Brief Summary: The purpose of this study is to conduct a prospective, longitudinal study on the My Diabetes Care (MDC) mobile intervention to assess usage patterns, user experience, and to uncover errors in functionality prior to a larger interventional trial.\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: OTHER: My Diabetes Care (MDC) Mobile\n",
      "Primary Outcome Measure: Usability, The System Usability Scale (SUS) is a valid measure of usability and assesses users' perceptions of ease of use, likability of the interface, and overall satisfaction using a 5- point Likert scale (strongly disagree to strongly agree). The ten items are scored on a five-point Likert scale. The item scores are summed and then converted to a score ranging from 0 (worst) to 100 (best). Based on prior research, a score above 68 would be above average and a score of 85 or above suggests excellent usability. The SUS has been used in several studies of patient facing health information technology (the article describing its psychometric properties has been cited over 500 times) and has excellent internal consistency reliability (Cronbach's alpha of 0.91)., One month follow-up (t1)|System Usage, System usage will be assessed by user analytics data capturing participants' total number of visits to MDC during the study period., One month follow-up (t1)|User Experience - Acceptance, User experience will be assessed by study-specific survey items administered to all study participants at the end of the study period (T1). Participants will be asked whether they would continue to use MDC going forward were it to remain available and the number of participants indicating continued use will be reported. Participants will be asked which features of MDC where most useful and for each MDC feature the number of participants indicating the feature was useful will be reported., One month follow-up (t1)\n",
      "Sponsor: Vanderbilt University Medical Center\n",
      "Collaborators: National Institutes of Health (NIH)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 67.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus-2\n",
      "Brief Summary: The purpose of this study is to improve blood glucose control in Type 2 Diabetes mellitus patients.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: BIOLOGICAL: stem cell transplantation\n",
      "Primary Outcome Measure: Reduction of insulin requirement by ≥ 50% by the end of 6 months of ABMSCT and Improvement in Glucagon stimulated C - peptide levels ., 6 months\n",
      "Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 30.0\n",
      "Funder Type: OTHER\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: \"Information Technology Methodology for Patient Motivation in Diabetes Management.\"\n",
      "Brief Summary: Type 2 diabetes is a chronic metabolic disorder requiring lifestyle modification and medicines, adherence to which has to be practised on a daily basis.\n",
      "\n",
      "Motivation of patients to adhere to treatment is difficult in clinical practice. It is well documented that majority of patients do not reach the glycaemic targets even in the centres of excellence. Regular short service messages (SMS) through cell phones could have a positive effect on behaviour and adherence to life style changes and compliance to drugs. It may be practical and feasible to use information technology as an effective and simple tool for motivating patients to adhere to the prescribed treatment regimen.\n",
      "\n",
      "In diabetic patients, frequent reminders regarding the need for adherence to LSM and drugs by the medical professionals will improve the compliance.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: BEHAVIORAL: Pre-coded messages|DRUG: Diabetes Treatment\n",
      "Primary Outcome Measure: Behavioural changes resulting in diet, better adherence to treatment., At intervals of three months for one year\n",
      "Sponsor: India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 200.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Remotely Delivered Episodic Future Thinking Intervention to Improve Management of Type 2 Diabetes\n",
      "Brief Summary: The goals of this project are to assess the efficacy of remotely delivered episodic future thinking for reducing delay discounting and improving management of type 2 diabetes, including glycemic control, weight loss, medication adherence, dietary intake, physical activity, and blood pressure. This will be accomplished by randomly assigning participants (N = 64) to episodic future thinking or control thinking groups, while tracking outcome measures before, during, and after the 4-month intervention, as well at a 6-month follow-up visit. Participants in both groups will also receive access to an information-based weight loss intervention.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: BEHAVIORAL: Episodic future thinking|BEHAVIORAL: Control Thinking\n",
      "Primary Outcome Measure: Change in glycemic control, Glycemic control will be assessed by hemoglobin A1C (HbA1c), a standardized diagnostic measure for type 2 diabetes., Baseline, 8 weeks, 16 weeks, and 24 weeks|Change in weight, Body weight will be measured using a digital scale., Baseline, 8 weeks, 16 weeks, and 24 weeks|Change in delay discounting, Delay discounting will be assessed using computerized behavioral tasks., Baseline, 8 weeks, 16 weeks, and 24 weeks\n",
      "Sponsor: Virginia Polytechnic Institute and State University\n",
      "Collaborators: Carilion Clinic|University at Buffalo|National Institute of Nursing Research (NINR)\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1|PHASE2\n",
      "Enrollment: 59.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive\n",
      "Brief Summary: to determine safety, efficacy and tolerability of BI 1356 versus placebo\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: BI 1356|DRUG: placebo\n",
      "Primary Outcome Measure: HbA1c Change From Baseline at Week 12, HbA1c is measured as a Percent. Thus, this change from baseline reflects the Week 12 HbA1c percent minus the baseline HbA1c percent. Means are treatment adjusted for baseline continuous HbA1c , creatinine clearance at baseline and previous anti-diabetic medication., Baseline and Week 12\n",
      "Sponsor: Boehringer Ingelheim\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 133.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Evaluation of Intermediate Care Clinics for Diabetes\n",
      "Brief Summary: The aim of this trial is to assess the effectiveness of intermediate care clinics for diabetes, compared to usual care.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: OTHER: intermediate care clinics (ICCs)\n",
      "Primary Outcome Measure: The percentage of participants reaching target control of HbA1c (7.0), and blood pressure (<140/80) and cholesterol (<4 mmol/l),, 18 months\n",
      "Sponsor: University Hospitals, Leicester\n",
      "Collaborators: Warwick Medical School\n",
      "Sex: ALL\n",
      "Age: CHILD, ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 1997.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Home-Based Intervention to the Diabetics\n",
      "Brief Summary: Why is the research needed?\n",
      "\n",
      "* This study reflects the complexity of the process that patients with diabetes are experiencing when staying at home away from the supervision of health professionals. In this context, there is a gap in the literature on home care of diabetes.\n",
      "* The barriers, facilitators and the other perceptions that affect each diabetic's compliance with the disease-related recommendation are different. Nurses need to be aware of this.\n",
      "* For this reason, according to the Health Belief Model, an original study was conducted to evaluate the nursing intervention program's results on patient care and cost-effectiveness in a home for supporting self-management of diabetic patients.\n",
      "\n",
      "Hypotheses of the Study Patients with diabetes undergoing home-based nursing interventions in line with the Health Belief Model.\n",
      "\n",
      "H1: have higher mean scores for the Health Belief Model Scale than the control group.\n",
      "\n",
      "H2: have higher mean scores for the Self-Efficacy Scale than the control group. H3: have lower HbA1c levels than the control group. H4: have lower blood glucose levels (BGL) than the control group. H5: have lower blood pressure levels than the control group. H6: have lower BMI levels than the control group. H7: have fewer hospital admissions due to an acute or chronic complication than the control group.\n",
      "\n",
      "H8: have a lower complication-related cost rate than the control group.\n",
      "Condition: Diabetes Mellitus, Type 2|Home Visit\n",
      "Intervention: OTHER: Home visits, health education\n",
      "Primary Outcome Measure: Health Belief Model Scale in Patients with Diabetes, The Health Belief Model Scale was developed in China, the validity and reliability study of the Turkish version of the scale was conducted in 2007 and the Cronbach's alpha value was 0.72 and 0.90 respectively. The subscales of the scale were as follows: perceived Susceptibility (5 items), Perceived Severity (3 items), Perceived Benefits (7 items), Perceived Barriers (11 items) and Recommended health-related activities (10 items).\n",
      "\n",
      "The items of the scale are evaluated in a 5-point Likert scale, from 1 (I strongly disagree) to 5 (I strongly agree). Every subscale mean isdetermined by dividing the total points of all thesubscale items by the total number of items. The total scale score mean is calculated by dividing the totalpoints of all the items by the total number of items. A positive health belief of 4 points and above; a score below 4 is interpreted as a negative health belief., 6 month|Diabetes Management Self-Efficacy Scale for Patients with Type 2 Diabetes, Diabetes Management Self-Efficacy Scale was developed in 1999, the validity and reliability study of the Turkish version of the scale was conducted in 2001. The Cronbach's alpha value was 0.89 for both versions .The scale has 4 subscales: nutrition specific and weight, physical exercise, and blood sugar, nutrition general and medical treatment. The tool has 20 items. The items are in a 5-point Likert scale from 1 (absolutely no) to 5 (absolutely yes).The lowest possible score from the scale is 20, the highest is 100., 6 month|Fasting plasma glucose level (mg/dl), The mean of plasma glucose level (milligram / deciliter) was used to compare patients' diabetic control and evaluate pre- and post-intervention values in the study process., 6 month|Postprandial glucose level (mg/dl), The mean of postprandial glucose level (milligram / deciliter) was used to compare patients' diabetic control and evaluate pre- and post-intervention values in the study process., 6 month|Hemoglobin A1c level (%), The mean of Hemoglobin A1c level (per cent) was used to compare patients' diabetic control by 3 months period and evaluate pre- and post-intervention values in the study process., 6 month|Body mass index (kg/m2), Body mass index is important for metabolic control of diabetic patients. For this outcome weight and height of patients were measured. Then body mass index was calculated by the formula (weight (kilogram) / height (meter) x height (meter)). Body mass index were recorded kilogram/meter2., 6 month|Blood pressure level (mmHg), Blood pressure levels were recorded milimeters mercury. Systolic and Diastolic Blood Pressure levels were measured both. This outcome is essential for macrovasculer complications., 6 month|Costs via frequency of complication-related hospital admissions, To calculate the cost of hospitalization for each patient, consumables (blood glucose measuring equipment, wound care products, wound cover, sterile gloves, catheter, urine bag, pen needle, infusion pump set) and time spent by the nurse (30 minutes for each patient) were determined. The cost of the time spent by the nurse was based on a new graduate nurse's salary and was calculated by using the formula '' salary ($)/ working time of May 2017 x 0.5 hours''., 6 month\n",
      "Sponsor: Dilay AÇIL,PhD\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 81.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Mechanisms by Which Strength Training Ameliorates the Metabolic Syndrome\n",
      "Brief Summary: Prevention and treatment strategies for diabetes use exercise as the cornerstone. Even though endurance training and strength training both improve insulin resistance, strength training may be better suited for persons at risk for type 2 diabetes. We will expand our pilot studies of muscle adaptation induced by resistance exercise training to determine the biochemical mechanisms that will cause people with the Metabolic Syndrome to secure major benefit from intense strength training.\n",
      "Condition: Metabolic Syndrome\n",
      "Intervention: BEHAVIORAL: strength training\n",
      "Primary Outcome Measure: euglycemic clamp steady state glucose infusion rate (clamp GIR), pre- post- intervention\n",
      "Sponsor: East Tennessee State University\n",
      "Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 50.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Effects of Linagliptin on Endothelial Function\n",
      "Brief Summary: This study is planned to evaluate if linagliptin can improve endothelial function in patients with type 2 diabetes mellitus. In addition, the effect of linagliptin on arginine bioavailability ratios and postchallenge glycaemic control will be studied.\n",
      "Condition: Type 2 Diabetes|Coronary Artery Disease\n",
      "Intervention: DRUG: Linagliptin|DRUG: Placebo\n",
      "Primary Outcome Measure: Changes in Endothelial Function (FMD - Flow Mediated Dilatation) From Baseline to 12 Weeks, Endothelium-dependent FMD following reactive hyperaemia was examined in the brachial artery according to the guidelines described by Coretti et al (J Am Coll Cardiol. 2002;39(2):257-65). FMD-diameter is calculated as the average of the three diameter measurements following reactive hyperaemia. FMD was calculated as the percent change in diameter compared to baseline. Flow-mediated dilation is reported such as \"percentage of change in diameter (%)\"., 12 weeks\n",
      "Sponsor: Medical University of Graz\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE4\n",
      "Enrollment: 49.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: An Observational Study Investigating the Effectiveness of Pravastatin on Renal Function in Korean Dyslipidemic Patients With Type 2 Diabetes\n",
      "Brief Summary: This study investigated the effectiveness of pravastatin on renal function in Korean dyslipidemic patients with Type 2 diabetes.\n",
      "Condition: Dyslipidemia Associated With Type II Diabetes Mellitus\n",
      "Intervention: DRUG: Pravastatin\n",
      "Primary Outcome Measure: Percentage Change Rate From Baseline in the Modification of Diet in Renal Disease(MDRD) Estimated Glomerular Filtration Rate (eGFR) at Week 24 After Routine Care of Pravastatin Administration, The following formula was used to calculate MDRD eGFR:\n",
      "\n",
      "MDRD eGFR (mL/min/1.73 m\\^2) = 186 x (serum creatinine) -1.154 x (age)-0.203 x (0.742 if female), Week 24 post-dose\n",
      "Sponsor: Daiichi Sankyo\n",
      "Collaborators: Daiichi Sankyo Korea Co., Ltd.\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 2972.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Improving Risk Factors for Diabetes Complications in Primary Care\n",
      "Brief Summary: The purpose of this study is to test an intervention in primary care clinics to improve three risk factors for diabetes complications: glucose control, blood pressure and cholesterol. Subjects in the study will be clinic staff and clinicians, not patients. The intervention is Practice Facilitation. Practice facilitation occurs when a trained facilitator meets with a team of staff and clinicians in each practice over a period of several months. Facilitation meetings create time for learning and reflection by members of the team and improves their communication so that they can adopt and implement a strategy to improve patient care\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: BEHAVIORAL: Practice Facilitation\n",
      "Primary Outcome Measure: glycosylated hemoglobin, 36 months\n",
      "Sponsor: The University of Texas Health Science Center at San Antonio\n",
      "Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\n",
      "Sex: ALL\n",
      "Age: CHILD, ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 2493.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Ongoing Diabetes Self-Management Support in Church-Based Settings\n",
      "Brief Summary: African Americans are twice as likely to have diabetes compared to their White counterparts and experience higher rates of diabetes-related complications. Diabetes-related health disparities underscore the need for effective, culturally tailored approaches to promote and sustain diabetes self-management over time. Diabetes self-management education (DSME) is effective in improving diabetes outcomes in the short-term. However, many adults with diabetes cannot sustain achieved improvements without continued follow-up and support. The 2012 revisions of both the National Standards for Diabetes Care 6 and the National Standards for DSME and Support emphasize the importance of providing both initial DSME and on-going diabetes self-management support (DSMS) to assist people with diabetes in maintaining effective self-management throughout a lifetime. While a great deal is understood about how to provide effective, initial DSME, less is known about who, where, when, and how to provide effective, sustained DSMS. One significant challenge is that DSME is a covered benefit in the healthcare system, while DSMS is not. This ultimately limits access and availability of DSMS programs, especially for low-income African Americans. Accordingly, there is critical need to develop, evaluate, and understand effective DSMS models that are ongoing, patient-driven, and embedded in the community.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: BEHAVIORAL: Parish nurse|BEHAVIORAL: Peer Support\n",
      "Primary Outcome Measure: Hemoglobin A1C, Measure of long-term glucose control, Baseline, 3, 9, 15, 27 months\n",
      "Sponsor: University of Michigan\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 94.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus\n",
      "Brief Summary: A multi-year clinical study to improve tools for measuring the function of insulin-producing beta cells in people with type 2 diabetes mellitus.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: Unknown\n",
      "Primary Outcome Measure: Repeatability of the meal tolerance test and the arginine stimulation test, as indicated by the ICC (intraclass correlation coefficient), Up to 28 days\n",
      "Sponsor: Foundation for the National Institutes of Health\n",
      "Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Juvenile Diabetes Research Foundation|Amylin Pharmaceuticals, LLC.|Merck Sharp & Dohme LLC|Pfizer|Eli Lilly and Company|Takeda|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Novartis\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 20.0\n",
      "Funder Type: OTHER\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Identify Bacteria Associated With Metabolic Diseases That Reside Both in Intestinal Crypts and in Blood\n",
      "Brief Summary: The investigators will compare 16sRDNA profile in cases and controls in order to identify bacteria associated with metabolic diseases that reside both in intestinal crypts and in blood.\n",
      "Condition: Obesity\n",
      "Intervention: OTHER: obese patients|OTHER: diabetic patients|OTHER: patients free of obesity and diabetes|OTHER: patients free type 2 diabetes\n",
      "Primary Outcome Measure: rDNA comparison between cases and controls, Comparison of 16sRDNA profile in cases and controls in order to identify bacteria associated with metabolic diseases that reside both in intestinal crypts and in blood., 36 months\n",
      "Sponsor: University Hospital, Toulouse\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 99.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes\n",
      "Brief Summary: To define the relative efficacy, safety and tolerability profiles of oral daily MBX-2982 at three different daily doses vs. placebo and sitagliptin 100 mg when administered for up to 4 weeks in patients that are treatment-naive or taking a single anti-diabetic medication (non-TZD, non-injectable).\n",
      "Condition: Diabetes\n",
      "Intervention: DRUG: MBX-2982|DRUG: MBX-2982|DRUG: MBX-2982|DRUG: Sitagliptin|DRUG: placebo\n",
      "Primary Outcome Measure: Evaluate the effect of MBX-2982 on the absolute and percent change from baseline and placebo in mean weighted average of 14-point blood glucose levels associated with a standardized breakfast and lunch, 4 weeks\n",
      "Sponsor: Gilead Sciences\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE2\n",
      "Enrollment: 100.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients\n",
      "Brief Summary: The purpose of this study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of PF-06291874 in Type 2 Diabetes patients.\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: PF-06291874|DRUG: Placebo\n",
      "Primary Outcome Measure: Number of Participants Had Protocol-Defined Total Hypoglycemic Adverse Event (HAE) - Part A, A hypoglycemic event (HAE) was identified by characteristic symptoms or blood glucose levels. Hypoglycaemia was assessed and reported in several categories: severe hypoglycaemia, documented symptomatic hypoglycaemia, asymptomatic hypoglycaemia, and probable hypoglycaemia., Day 1 up to 7-11 days after last dose of study drug|Number of Participants Had Protocol-Defined Total Hypoglycemic Adverse Event (HAE) - Part B, A hypoglycemic event (HAE) was identified by characteristic symptoms or blood glucose levels. Hypoglycaemia was assessed and reported in several categories: severe hypoglycaemia, documented symptomatic hypoglycaemia, asymptomatic hypoglycaemia, and probable hypoglycaemia., Day 1 up to 7-11 days after last dose of study drug|Number of Participants With Electrocardiograms (ECGs) Data Met Criteria of Potential Clinical Concern - Part A, ECG criteria of potential clinical concern were 1), PR interval: greater than or equal to (\\>=)300 milliseconds (msec); \\>=25 percent (%) increase when baselinegreater than (\\>)200 msec; or increase \\>=50% when baseline less than or equal to (\\<=)200 msec; 2), QRS interval: \\>=140 msec; \\>=50% increase from baseline; 3), QT interval: \\>=500 msec, QTc interval using cridericia's formula (QTcF interval): absolute value \\>=450 - \\<480 msec, \\>=480-\\<500 msec, \\>500 msec; absolute change 30 - \\<60, \\>=60 msec., Predose (0),4,6,8,12,24 hours on Days 1 and 14; 8 hours post dose on Days 3,7,11 for all Cohorts ; predose on Day 17 for Cohorts 1- 4A and 1B; predose on Days 21 and 28 for Cohorts 5A and 2B.|Number of Participants With ECGs Data Met Criteria of Potential Clinical Concern - Part B, ECG criteria of potential clinical concern were 1), PR interval: \\>=300 msec; \\>=25% increase when baseline \\>200 msec; or increase \\>=50% when baseline \\<=200 msec; 2), QRS interval: \\>=140 msec; \\>=50% increase from baseline; 3), QT interval: \\>=500 msec, QTcF interval: absolute value \\>=450 - \\<480 msec, \\>=480-\\<500 msec, \\>500 msec; absolute change 30 - \\<60, \\>=60 msec., Predose (0),4,6,8,12,24 hours on Days 1 and 14; 8 hours post dose on Days 3,7,11 for all Cohorts ; predose on Day 17 for Cohorts 1- 4A and 1B; predose on Days 21 and 28 for Cohorts 5A and 2B.|Number of Participants With Vital Signs Data Met Criteria of Potential Clinical Concern - Part A, Vital signs included blood pressure (BP; supine, sitting and standing) and pulse rate. Vital signs criteria of potential clinical concern were 1), BP: systolic BP (SBP) greater than or equal to (\\>=) 30 millimeters of mercury (mm Hg) change from grand baseline in same posture, systolic less than (\\<) 90 mm Hg; diastolic BP (DBP) \\>=20 mm Hg change from grand baseline in same posture, diastolic \\<50 mm Hg; 2), pulse rate (supine): \\<40 or greater than (\\>) 120 beats per minute (bpm)., Predose (0),4,6,8,12,24 hours on Days 1 and 14; 8 hours post dose on Days 3,7,11 for all Cohorts ; predose on Day 17 for Cohorts 1- 4A and 1B; predose on Days 21 and 28 for Cohorts 5A and 2B.|Number of Participants With Vital Signs Data Met Criteria of Potential Clinical Concern - Part B, Vital signs included blood pressure (BP; supine, sitting and standing) and pulse rate. Vital signs criteria of potential clinical concern were 1), BP: SBP \\>= 30 mm Hg change from grand baseline in same posture, SBP \\< 90 mm Hg; DBP \\>=20 mm Hg change from grand baseline in same posture, DBP\\<50 mm Hg; 2), pulse rate (supine): \\<40 or \\> 120 bpm., Predose (0),4,6,8,12,24 hours on Days 1 and 14; 8 hours post dose on Days 3,7,11 for all Cohorts ; predose on Day 17 for Cohorts 1- 4A and 1B; predose on Days 21 and 28 for Cohorts 5A and 2B.|Number of Participants With Any Abnormal Laboratory Test Results - Part A, The laboratory test included: hematology (hemoglobin, hematocrit, red blood cell count, MCV, MCH, MCHC, platelets, white blood cell count, absolute lymphocytes, absolute total neutrophils, absolute basophils, absolute eosinophils and absolute monocytes), coagulation (PPT, prothrombin), liver function(total bilirubin, AST, ALT, alkaline phosphatase, total protein and albumin), renal function (blood urea nitrogen, creatinine, uric acid), Lipids (cholesterol, HDL cholesterol, LDL cholesterol, triglycerides), Electrolytes (sodium, potassium, chloride, calcium, venous bicarbonate), clinical chemistry (glucose, glycosylated, hemoglobin, amylase, lipase), urinalysis dipstick (urine PH, urine glucose, urine ketones, urine protein, urine urobilinogen, urine bilirubin, urine nitrite, urine leukocyte, esterase), urinalysis microscopy (urine RBC, urine WBC, urine bacteria). Laboratory abnormality was determined by the investigator based on pre-defined criteria., Predose on Days 0,3,7,11 for all cohorts and 14 and 17 for Cohorts 1- 4A and 1B, and pre-dose on Days 21 and 28 for Cohorts 5A and 2B.|Number of Participants With Any Abnormal Laboratory Test Results - Part B, The laboratory test included: hematology (hemoglobin, hematocrit, red blood cell count, MCV, MCH, MCHC, platelets, white blood cell count, absolute lymphocytes, absolute total neutrophils, absolute basophils, absolute eosinophils and absolute monocytes), coagulation (PPT, prothrombin), liver function(total bilirubin, AST, ALT, alkaline phosphatase, total protein and albumin), renal function (blood urea nitrogen, creatinine, uric acid), Lipids (cholesterol, HDL cholesterol, LDL cholesterol, triglycerides), Electrolytes (sodium, potassium, chloride, calcium, venous bicarbonate), clinical chemistry (glucose, glycosylated, hemoglobin, amylase, lipase), urinalysis dipstick (urine PH, urine glucose, urine ketones, urine protein, urine urobilinogen, urine bilirubin, urine nitrite, urine leukocyte, esterase), urinalysis microscopy (urine RBC, urine WBC, urine bacteria). Laboratory abnormality was determined by the investigator based on pre-defined criteria., Predose on Days 0,3,7,11 for all cohorts and 14 and 17 for Cohorts 1- 4A and 1B, and pre-dose on Days 21 and 28 for Cohorts 5A and 2B.|Single Dose Maximum Plasma Concentration (Cmax) for PF-06291874 - Part A, Cmax was maximum plasma concentration. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for pharmacokinetic (PK) analysis were collected at 0, 2, 4, 6, 8, 12, 19 and 24 hours post dose., 0 hour (pre-dose), 2, 4, 6, 8, 12, 19, 24 hours post-dose on Day 1|Single Dose Normalized Cmax (Cmax[dn]) for PF-06291874 - Part A, Cmax (dn) was dose normalized maximum plasma concentration. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for pharmacokinetic (PK) analysis were collected at 0, 2, 4, 6, 8, 12, 19 and 24 hours post dose., 0 hour (pre-dose), 2, 4, 6, 8, 12, 19, 24 hours post-dose on Day 1|Single Dose Cmax for PF-06291874 - Part B, Cmax was maximum plasma concentration. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19 and 24 hours post dose., 0 hour (pre-dose), 2, 4, 6, 8, 12, 19, 24 hours post-dose on Day 1|Single Dose Normalized Cmax (Cmax[dn]) for PF-06291874 - Part B, Cmax (dn) was dose normalized maximum plasma concentration. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19 and 24 hours post dose, 0 hour (pre-dose), 2, 4, 6, 8, 12, 19, 24 hours post-dose on Day 1|Single Dose Time at Which Cmax Occurred (Tmax) for PF-06291874 - Part A, Tmax was time at which Cmax occurred. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., 0 hour (pre-dose), 2, 4, 6, 8, 12, 19, 24 hours post-dose on Day 1|Single Dose Tmax for PF-06291874 - Part B, Tmax was time at which Cmax occurred. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., 0 hour (pre-dose), 2, 4, 6, 8, 12, 19, 24 hours post-dose on Day 1|Single Dose AUCtau (Area Under the Concentration-time Profile From Time Zero to Time Tau, the Dosing Interval, Where Tau = 24 Hours) for PF-06291874 - Part A, AUCtau was area under the concentration-time profile from time zero to time tau, the dosing interval, where tau = 24 hours. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., 0 hour (pre-dose), 2, 4, 6, 8, 12, 19, 24 hours post-dose on Day 1|Single Dose AUCtau for PF-06291874 - Part B, AUCtau was area under the concentration-time profile from time zero to time tau, the dosing interval, where tau = 24 hours. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., 0 hour (pre-dose), 2, 4, 6, 8, 12, 19, 24 hours post-dose on Day 1|Multiple Dose Cmax for PF-06291874 - Part A, Cmax was maximum plasma concentration. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose Cmax for PF-06291874 - Part B, Cmax was maximum plasma concentration. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose Tmax for PF-06291874 - Part A, Tmax was time at which Cmax occurred. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose Tmax for PF-06291874 - Part B, Tmax was time at which Cmax occurred. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose AUCtau for PF-06291874 - Part A, AUCtau was area under the concentration-time profile from time zero to time tau, the dosing interval, where tau = 24 hours. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose AUCtau for PF-06291874 - Part B, AUCtau was area under the concentration-time profile from time zero to time tau, the dosing interval, where tau = 24 hours. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose Half Life for PF-06291874, Plasma half-life was the time measured for the plasma concentration to decrease by one half. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose Cmin (Lowest Plasma Concentration Observed During the Dosing Interval) for PF-06291874 - Part A, Cmin was the lowest plasma concentration observed during the dosing interval. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose Cmin for PF-06291874 - Part B, Cmin was the lowest plasma concentration observed during the dosing interval. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose Apparent Clearance (CL/F) for PF-06291874 - Part A, CL/F was multiple dose apparent clearance. The 24-hour urine samples for PK analysis were collected on Day 14 over 2 collection periods (0-6 hours and 6-24 hours)., on Day 14 over 2 collection periods (0-6 hours and 6-24 hours).|Multiple Dose CL/F for PF-06291874 - Part B, CL/F was multiple dose apparent clearance. The 24-hour urine samples for PK analysis were collected on Day 14 over 2 collection periods (0-6 hours and 6-24 hours)., on Day 14 over 2 collection periods (0-6 hours and 6-24 hours).|Multiple Dose Apparent Volume of Distribution (Vz/F) for PF-06291874- Part A and Part B, Vz/F was apparent volume of distribution. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose Observed Accumulation Ratio (Rac) for PF-06291874 - Part A, Rac was observed accumulation ratio. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose Rac for PF-06291874 - Part B, Rac was observed accumulation ratio. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose Rac for Cmax (Rac,Cmax) for PF-06291874 - Part A, Rac,cmax was observed accumulation ratio for Cmax. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose Rac,Cmax for PF-06291874 - Part B, Rac,cmax was observed accumulation ratio for Cmax. Blood samples (3 mL) to provide a minimum of approximately 1.2 mL plasma for PK analysis were collected at 0, 2, 4, 6, 8, 12, 19, 24 hours post dose., Predose (0), 2, 4, 6, 8, 12, 19, 24 hours post dose on Day 14|Multiple Dose Percent of Cumulative Amount of Drug Recovered Unchanged in Urine Over the Dosing Interval τ(Aetau%) for PF-06291874, Aetau% was percent of cumulative amount of drug recovered unchanged in urine over the dosing interval τ. The 24-hour urine samples for PK analysis were collected on Day 14 over 2 collection periods (0-6 hours and 6-24 hours)., on Day 14 over 2 collection periods (0-6 hours and 6-24 hours).|Multiple Dose Renal Clearance (CLr) for PF-06291874, CLr was renal clearance. The 24 hour urine samples for PK analysis were collected on Day 14 over 2 collection periods (0-6 hours and 6-24 hours), on Day 14 over 2 collection periods (0-6 hours and 6-24 hours).|Changes From Baseline for Mean Daily Glucose (mg/dL) on Day 14 (AUC Approach) - Part A, A MMTT was administered on Days -1 and 14 for all cohorts. Blood samples for analysis of glucose were collected at nominal time 0, 0.25, 0.5, 1, 1.5, 2, 3, 4, 6, 10, 12, 15, 19 and 24 hours on Days -1 and 14 for all cohorts. MDG was computed by AUC24/24 hours of the glucose values measured., 0, 0.25, 0.5, 1, 1.5, 2, 3, 4, 6, 10, 12, 15, 19 and 24 hours on Days -1 and 14 for all cohorts, and on Day 28 for PF-06291874 100 mg Part A and PF-06291874 30 mg Part B.|Changes From Baseline for Mean Daily Glucose (mg/dL) on Day 14 (AUC Approach) - Part B, A MMTT was administered on Days -1 and 14 for all cohorts. Blood samples for analysis of glucose were collected at nominal time 0, 0.25, 0.5, 1, 1.5, 2, 3, 4, 6, 10, 12, 15, 19 and 24 hours on Days -1 and 14 for all cohorts. MDG was computed by AUC24/24 hours of the glucose values measured., 0, 0.25, 0.5, 1, 1.5, 2, 3, 4, 6, 10, 12, 15, 19 and 24 hours on Days -1 and 14 for all cohorts, and on Day 28 for PF-06291874 100 mg Part A and PF-06291874 30 mg Part B.|Changes From Baseline for Mean Daily Glucose (mg/dL) on Day 28 (AUC Approach), A MMTT was administered on Days -1 for all cohorts, and on Day 28 for PF-06291874 100 mg Part A and PF-06291874 30 mg Part B. Blood samples for analysis of glucose were collected at nominal time 0, 0.25, 0.5, 1, 1.5, 2, 3, 4, 6, 10, 12, 15, 19 and 24 hours on Days -1 and 14 for all cohorts, and on Day 28 for PF-06291874 100 mg Part A and PF-06291874 30 mg Part B. MDG was computed by AUC24/24 hours of the glucose values measured., 0, 0.25, 0.5, 1, 1.5, 2, 3, 4, 6, 10, 12, 15, 19 and 24 hours on Days -1 and 14 for all cohorts, and on Day 28 for PF-06291874 100 mg Part A and PF-06291874 30 mg Part B.\n",
      "Sponsor: Pfizer\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 117.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Effect of Camel Milk With Probiotic on Type 2 Diabetes Mellitus\n",
      "Brief Summary: The purpose of this study is to investigate the effects of dietary supplement with Camel Milk containing Bifidobacterium animalis A6 on the plasma glucose and other related cytokines in patients with type 2 diabetes mellitus. 45 patients with type 2 diabetes mellitus were recruited, and a Double Blind Randomized Parallel Controlled Trial was performed. The fasting glycaemia, 2 hour postprandial glycaemia, insulin, uric acid and serum lipid (total cholesterol, total triglyceride, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol ) were measured as Primary Outcome. The Fecal microbiome, fecal metabolites, gut hormones (amylin, ghrelin, glucagon-like peptide 1, pancreatic polypeptide), inflammation cytokines (TNF-α, IL-6, MCP-1), myokines (FGF-21, irisin, osteocrin/musclin, osteonectin) and adipokines (adiponectin, resistin, lipocalin-2, adipsin) and body composition analysis were also assessed.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DIETARY_SUPPLEMENT: Camel milk containing Bifidobacterium animalis A6|DIETARY_SUPPLEMENT: Camel milk|DIETARY_SUPPLEMENT: Bifidobacterium animalis A6|DIETARY_SUPPLEMENT: Cow milk\n",
      "Primary Outcome Measure: Changes in fasting blood glucose and 2 hour postprandial blood glucose in millimole per liter and insulin in μU/mL, follow up the patients at week 0, 4, 4 weeks|Changes in lipid profiles (total cholesterol, total triglyceride, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in millimole per liter), follow up the patients at week 0, 4, 4 weeks\n",
      "Sponsor: China Agricultural University\n",
      "Collaborators: Beijing Chinese Medicine Hospital-Pinggu Hospital\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 45.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Effectiveness of Nutrition Education Intervention on Glycemic Control (HbA1c)\n",
      "Brief Summary: Aim: To evaluate the effect of nutrition education intervention (NEI) on glycemic control and other diabetes-related outcomes of patients with type 2 diabetes mellitus (T2DM), at a tertiary health Center, in Basrah, Iraq. Participants and setting: The study was involved 208 participants (20-64 years) diagnosed with T2DM at least 6 months before the study and had poorly controlled diabetes (HbA1c ≥ 7%). The study setting is the outpatient clinics at a tertiary health Center in Basrah, Iraq. Intervention: This randomized controlled trial design. The participants were allocated to either intervention group (IG), or control group (CG). A total sample size was 208 participants with T2DM (104 per group) to detect a 5% reduction in glycemic control (HbA1c), at visit time 1 (3 months after intervention) and visit time 2 (3 months after following up) and allowing 30% drop out rate. The intervention period is 22 weeks long with the following mechanisms: the curriculum (twelve weekly classes, 1 to 1.5 hrs. each); follow-up classes (one monthly each lasting 1 to 1.5 hrs.); nutrition education materials (pamphlets) and reminder calling before each session for IG. The participants in the CG received classes about diabetes and its complications with some advice related to physical activity on different days on IG. Besides, they received the same pamphlets at the end of the study. Both groups continued with the usual medical care at respective Center. The participants in the IG group received nutrition education classes. The classes are offered in the meeting hall in the center by face- to- face using the simple Arabic language, which utilized lecture method using PowerPoint presentations and whiteboard, lecture-discussion groups, and related videos. The nutrition education classes were administered by a nutritionist and a team of endocrinologists, and diabetes experts. The content and strategies utilized in the classes were based on Health Belief Model theory (HBM). Outcomes: the outcomes were evaluated at visit time 1 (at 12 weeks of intervention) and at visit time 2 (at 22 weeks of the follow-up period) for both groups. The outcomes were included HbA1c, metabolic parameters, nutritional status, HBM constructs, diabetes knowledge (DK), and health literacy (HL). It is assumed that the NEI will reduce the HbA1c levels by at least 0.5% at three months and the levels will be lower in IG compared with CG, and the lower levels will be continued at 22 weeks in IG.\n",
      "Condition: Type 2 Diabetes|Diet, Healthy|Health Knowledge, Attitudes, Practice\n",
      "Intervention: BEHAVIORAL: Nutrition Education Intervention\n",
      "Primary Outcome Measure: Glycemic control, Glycated Hemoglobin (HbA1c), taken from medical records (%) change, From baseline to 12 weeks and 22 weeks\n",
      "Sponsor: Universiti Putra Malaysia\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 208.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Vitamin D and Omega-3 Inhibit Metabolic Syndrome\n",
      "Brief Summary: The study will test the hypothesis that supplementing the diet of subjects with Metabolic Syndrome with 2000 IU vitamin D and 1.8 g omega-3 fatty acids (EPA + DHA) per day, will facilitate weight loss, improve body composition and reduce metabolic and biochemical risk factors associated with type II diabetes and cardiovascular disease. Adult men and women who meet the International Diabetes Federation criteria for Metabolic Syndrome will be enrolled and embark on a 16 week diet and exercise intervention using a low glycemic index diet with or without the supplementary vitamin D and omega-3. Subjects will be counseled weekly and blood collected at weeks 0 and 16.\n",
      "Condition: Type 2 Diabetes Mellitus|Hypertension|Hyperlipidemia|Obesity\n",
      "Intervention: OTHER: low glycemic diet|DIETARY_SUPPLEMENT: vitamin D omega-3\n",
      "Primary Outcome Measure: body weight, body weight will be measured to nearest 0.5 kg weekly, up to 16 weeks\n",
      "Sponsor: University of Guelph\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 40.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes\n",
      "Brief Summary: At least 30% of patients initially treated with sulphonylureas for NIDOM will have a poor response, and in the remaining 70% the subsequent failure rate is approximately 4% to 5% per year. BRL 49653C has a different mechanism of action to the sulphonylureas, and therefore the effects on fasting plasma glucose and Hb A1c are expected to be additive. Since circulatory insulin levels should decrease, and plasma glucose should be regulated, these combinations are also anticipated to slow both the progression of diabetic complications and delay the need for exogenous insulin.\n",
      "\n",
      "The proposed study is intended primarily to determine the effectiveness of BRL 49653C by measure of glucose homeostasis as determined by Hb A1c and fasting plasma glucose, when added to sulphonylurea therapy (sulphonylureas are limited to: glibenclamide, glipazide and gliclazide). In addition, the clinical safety of BRL 49653C will be assessed in this patient population. The starting doses have been selected based on dose response studies examining safety, tolerability and efficacy in the U.S.A.\n",
      "Condition: Diabetes Mellitus Non Insulin Dependent Oral Agent Therapy\n",
      "Intervention: DRUG: BRL 49653C|DRUG: Placebo\n",
      "Primary Outcome Measure: To determine the effectiveness of BRL 49653C (2 mg bd) compared to placebo when added to sulphonylurea therapy, for 24 weeks in out-patients with NIDDM., Primary: Change from baseline for Hb A1c at week 24.\n",
      "\n",
      "Secondary: Mean change from baseline for:\n",
      "\n",
      "fasting plasma glucose,insulin levels, immune reactive,lipid levels (ie.total cholesterol, HDL-cholesterol, LDL cholesterol, triglycerides), body weight (WHR), vital signs (systolic, diastolic blood pressure and heart rate), 7 months\n",
      "Sponsor: National Taiwan University Hospital\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 77.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Vildagliptin and Endothelium-dependent Vasodilatation\n",
      "Brief Summary: Rationale: Cardiovascular complications in type 2 diabetes are the leading cause of morbidity and mortality associated with the disease. Endothelial dysfunction is regarded as an important factor in these vascular complications.\n",
      "\n",
      "The introduction of glucagon-like peptide-1 (GLP-1) analogues and dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes is of special interest because of possible influences on endothelial function. Numerous reports have shown that GLP-1 improves endothelial function.\n",
      "\n",
      "Objective: To determine whether a four week treatment with vildagliptin compared to acarbose improves endothelial dysfunction in patients with type 2 diabetes mellitus.\n",
      "Condition: Type 2 Diabetes|Endothelial Dysfunction\n",
      "Intervention: DRUG: vildagliptin + acarbose|DRUG: acarbose + vildagliptin\n",
      "Primary Outcome Measure: Forearm vasodilator response to intra-arterial infusion of acetylcholine (endothelium-dependent) following treatment with vildagliptin and following active control with acarbose, 8 weeks\n",
      "Sponsor: Radboud University Medical Center\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 16.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Randomized Trial to Slow the Progression of Diabetes\n",
      "Brief Summary: The research objective of this one-year study is to test whether an evidence-based, low-cost mobile diabetes management package (DMP), with or without an incentive program grounded in economic theory (M-POWER Rewards), can effectively and cost-effectively improve health outcomes for adults with type 2 diabetes.\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: BEHAVIORAL: Diabetes Management Package (DMP)|BEHAVIORAL: M-POWER Rewards\n",
      "Primary Outcome Measure: Change in HbA1c levels at Month 12, HbA1c or glycated hemoglobin is a measure of blood glucose levels. HbA1c blood tests will be conducted at baseline and Month 12 and the difference will be calculated., Baseline, Month 12\n",
      "Sponsor: Duke-NUS Graduate Medical School\n",
      "Collaborators: National Medical Research Council (NMRC), Singapore|SingHealth Polyclinics|Singapore General Hospital|Changi General Hospital\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 269.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs\n",
      "Brief Summary: Pathophysiology of diabetic cardiomyopathy (DCM) is yet unclear and gender differences at baseline and a specific treatment have not been indicated. The investigators already demonstrated the positive impact of phosphodiesterase type 5A (PDE5A) inhibition in men. The investigators' study aims to characterize DCM, measuring molecular and neuroendocrine assessment to relate to intramyocardial metabolism and cardiac kinetic. The investigators will perform a randomized, placebo-controlled, double-blind study enrolling 164 diabetic patients (females and males) with DCM, to evaluate gender responses to 6 months of PDE5A inhibitors (PDE5Ai). The investigators' study will describe gender differences in DCM features. The proposed research will test whether PDE5Ai could become a new target for antiremodeling drugs and to discover a molecular pathways affected by this class of drugs and a network of circulating markers for the early diagnosis, monitoring and prediction of response to treatment of DCM.\n",
      "Condition: Diabetic Cardiomyopathy|Diabetes Mellitus Type 2\n",
      "Intervention: DRUG: Tadalafil|DRUG: Placebo\n",
      "Primary Outcome Measure: Change from Baseline in Left Ventricular torsion (°) at 5 months, Change of Left ventricular torsion (°) assessed through CMR with tagging before and after treatment to heart failure and gender differences, time 0, +5 months\n",
      "Sponsor: University of Roma La Sapienza\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE4\n",
      "Enrollment: 120.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus\n",
      "Brief Summary: This is a trial in obese subjects who have poor lipid control with and without Type 2 diabetes mellitus to study the safety, tolerability and pharmacokinetics of multiple doses of PF-05231023\n",
      "Condition: Diabetes Melliuts, Type 2\n",
      "Intervention: OTHER: Placebo|DRUG: 25 mg PF-05231023|DRUG: 50 mg PF-05231023|DRUG: 100 mg PF-05231023|DRUG: 150 mg PF-05231023\n",
      "Primary Outcome Measure: Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs), An AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. An SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly. Treatment-emergent events were between first dose of study drug and up to 28 days after last dose that were absent before treatment or that worsened relative to pre-treatment state., Baseline up to 28 days after last dose|Number of Participants With Laboratory Abnormalities, Criteria for laboratory test abnormality: Hematology (hemoglobin, hematocrit, red blood corpuscles \\[RBC\\] count: less than \\[\\<\\]0.8\\*lower limit of normal \\[LLN\\], platelets: \\<0.5\\*LLN/greater than \\[\\>\\]1.75\\*upper limit of normal \\[ULN\\], leukocytes: \\<0.6\\*LLN or \\>1.5\\*ULN, lymphocytes, total neutrophils: \\<0.8\\*LLN or \\>1.2\\*ULN, basophils, eosinophil: \\<0.8\\*LLN, monocytes: \\>1.2\\*ULN); Liver Function (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase: \\>0.3\\*ULN, total protein, albumin: \\<0.8\\*LLN or \\>1.2\\*ULN); total bilirubin, direct bilirubin, indirect bilirubin: \\>1.5\\*ULN; Renal Function (blood urea nitrogen, creatinine: \\>1.3\\*ULN, uric acid: \\>1.2\\*ULN); Electrolytes (sodium: \\<0.95\\*LLN or \\>1.05\\*ULN, potassium, chloride, calcium, bicarbonate: \\<0.9\\*LLN or \\>1.1\\*ULN; creatine kinase: \\>2.0\\*ULN; glucose fasting: \\<0.6\\*LLN or \\>1.5\\*ULN, urine white blood corpuscles \\[WBC\\] and RBC: greater than or equal to (\\>=) 20/High Power Field \\[HPF\\])., Baseline up to Day 49|Number of Participants With Clinically Significant Vital Sign Abnormalities, Criteria for clinically significant vital signs abnormalities included supine/sitting pulse rate of \\<40 beats per minute (bpm) or \\>120 bpm, supine systolic blood pressure (SBP) of \\<90 millimeter of mercury (mmHg), \\>=30 mmHg maximum increase and decrease from baseline in same posture, supine diastolic blood pressure (DBP) of \\<50 mmHg; \\>=20 mmHg maximum increase and decrease from baseline in same posture., Baseline up to Day 49|Number of Participants With Clinically Significant Electrocardiogram Findings, Clinically significant ECG findings included PR interval \\>=300 milliseconds (msec) or \\>=25 percent (%) increase from baseline (if baseline PR interval \\>200 msec) or \\>=50% increase (if baseline PR interval less than or equal to \\[\\<=\\] 200 msec); QRS interval \\>=140 msec or \\>=50% increase from baseline; QT interval \\>=500 msec, corrected QT interval based on Fridericia's formula (QTcF) 450 to \\<480 msec, 480 to \\<500 msec, \\>=500 msec or \\>=30 msec but \\<60 msec increase from baseline or \\>=60 msec increase from baseline., Baseline up to Day 49|Number of Participants With Abnormal Physical Examinations, Physical examination included general examination and examination of head, ears, eyes, nose, mouth, throat, neck, abdomen, skin, heart, lungs, lymph nodes, and gastrointestinal and musculoskeletal and neurological system., Baseline up to Day 49|Thyroid Stimulating Hormone (TSH) Level at Baseline, Results are reported in micro international units per milliliter (mcIU/mL)., Baseline|Thyroid Stimulating Hormone (TSH) Level at Day 1, Day 1|Thyroid Stimulating Hormone (TSH) Level at Day 25, Day 25|Thyroid Stimulating Hormone (TSH) Level at Day 39, Day 39|Thyroid Stimulating Hormone (TSH) Level at Day 49, Day 49|Phosphate Level at Baseline, Baseline|Change From Baseline in Phosphate Level at Day 8, Baseline, Day 8|Change From Baseline in Phosphate Level at Day 15, Baseline, Day 15|Change From Baseline in Phosphate Level at Day 25, Baseline, Day 25|Change From Baseline in Phosphate Level at Day 49, Baseline, Day 49|Creatine Phosphokinase (CPK) Level at Baseline, Baseline|Change From Baseline in Creatine Phosphokinase (CPK) Level at Day 8, Baseline, Day 8|Change From Baseline in Creatine Phosphokinase (CPK) Level at Day 15, Baseline, Day 15|Change From Baseline in Creatine Phosphokinase (CPK) Level at Day 25, Baseline, Day 25|Change From Baseline in Creatine Phosphokinase (CPK) Level at Day 49, Baseline, Day 49|Serum N-terminal Propeptides of Type 1 Collagen (PINP) and C-Telopeptide Cross-Linking of Type 1 Collagen (CTX) Levels at Baseline, Baseline|Percent Change From Baseline in Serum N-terminal Propeptides of Type 1 Collagen (PINP) and C-Telopeptide Cross-Linking of Type 1 Collagen (CTX) Levels at Day 25, Baseline, Day 25|Percent Change From Baseline in Serum N-terminal Propeptides of Type 1 Collagen (PINP) and C-Telopeptide Cross-Linking of Type 1 Collagen (CTX) Levels at Day 39, Baseline, Day 39|Percent Change From Baseline Serum N-terminal Propeptides of Type 1 Collagen (PINP) and C-Telopeptide Cross-Linking of Type 1 Collagen (CTX) Levels at Day 49, Baseline, Day 49|Blood Osteocalcin and Bone-Specific Alkaline Phosphatase Levels at Baseline, Baseline|Percent Change From Baseline in Blood Osteocalcin and Bone-Specific Alkaline Phosphatase Levels at Day 25, Baseline, Day 25|Percent Change From Baseline in Blood Osteocalcin and Bone-Specific Alkaline Phosphatase Levels at Day 39, Baseline, Day 39|Percent Change From Baseline in Blood Osteocalcin and Bone-Specific Alkaline Phosphatase Levels at Day 49, Baseline, Day 49|Tartrate-resistant Acid Phosphatase Isoform 5b (TRAP 5b) Levels at Baseline, Baseline|Percent Change From Baseline in Tartrate-resistant Acid Phosphatase Isoform 5b (TRAP 5b) Levels at Day 25, Baseline, Day 25|Percent Change From Baseline in Tartrate-resistant Acid Phosphatase Isoform 5b (TRAP 5b) Levels at Day 39, Baseline, Day 39|Percent Change From Baseline in Tartrate-resistant Acid Phosphatase Isoform 5b (TRAP 5b) Levels at Day 49, Day 49|Average Urinary Calcium and Phosphate Levels Over 24 Hours at Baseline, Baseline|Change From Baseline in Average Urinary Calcium and Phosphate Levels Over 24 Hours at Day 24, Day 24|Number of Participants With Anti-PF-05231023 Antibodies and Neutralizing Antibodies at Day 1, Anti-PF-05231023 antibodies and neutralizing antibodies were analyzed only for participants who received PF-05231023 as per planned analysis. One sample at Day 1 was inadvertently tested for neutralizing antibody even though the corresponding anti-PF-05231023 antibody was negative., Day 1|Number of Participants With Anti-PF-05231023 Antibodies and Neutralizing Antibodies at Day 39, Anti-PF-05231023 antibodies and neutralizing antibodies were analyzed only for participants who received PF-05231023 as per planned analysis. One sample at Day 39 was inadvertently tested for neutralizing antibody even though the corresponding anti-PF-05231023 antibody was negative., Day 39|Number of Participants With Anti-PF-05231023 Antibodies and Neutralizing Antibodies at Day 49, Day 49\n",
      "Sponsor: Pfizer\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 107.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: PPAR - Combination With Metformin\n",
      "Brief Summary: A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination with Metformin Therapy in Subjects with Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone\n",
      "Condition: Diabetes Mellitus\n",
      "Intervention: DRUG: Muraglitazar\n",
      "Primary Outcome Measure: compare change from baseline in HbA1c after 24 weeks of treatment with muraglitazar + metformin vs placebo + metformin\n",
      "Sponsor: Bristol-Myers Squibb\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 534.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Evaluate Effects of Sprinkled Format REDUCOSE in a Carbohydrate-rich, Mixed Meal on Post-prandial Glycemia\n",
      "Brief Summary: This is a mechanistic, single-center, double-blind, placebo- and active-controlled, three-time-period, crossover study to evaluate the effect of sprinkled format REDUCOSE compared to placebo (double-blind; confirmative) and active control (open-label; acarbose - explorative) on post prandial glycemia in Asian patients with type 2 diabetes.\n",
      "Condition: Dietary Supplement\n",
      "Intervention: DIETARY_SUPPLEMENT: Dietary Supplement: Sprinkled Format REDUCOSE.|OTHER: Reference control|OTHER: Active comparator\n",
      "Primary Outcome Measure: Post-prandial glycemic excursion (ARMs A and B), Incremental area under the curve post-prandial glycemic excursion (iAUC 0-1h, iAUC 0-2h, iAUC 0-3h)., 0 ,15, 30, 60, 120, and 180 minutes.\n",
      "Sponsor: Société des Produits Nestlé (SPN)\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 30.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity\n",
      "Brief Summary: This study in healthy men and women looks at the injection site experience of the DV3396 pen to that of the PDS290 pens when both pens are used to deliver 0.25 mg semaglutide subcutaneously (s.c., under the skin). Participants will receive 2 single doses of semaglutide 0.25 mg on 1 day. The 2 injections will be given at least 30 minutes apart, one in each side of the stomach. Participants will be in the clinic research center for 1 day. A follow-up phone call will take place between 4 and 5 weeks after the injections were given.\n",
      "Condition: Healthy Volunteers Diabetes Mellitus, Type 2|Healthy Volunteers Overweight|Healthy Volunteers Obesity\n",
      "Intervention: DRUG: Semaglutide (administered by DV3396 pen)|DRUG: Semaglutide (administered by PDS290 pen)\n",
      "Primary Outcome Measure: Intensity of Injection Site Pain, The intensity of injection site pain was measured on a visual analogue scale (VAS). The VAS consists of a horizontal 100 millimetres (mm) line where 0 mm corresponded to no pain and 100 mm corresponded to unbearable pain. After each injection, the participants rated their pain perception at the VAS by marking a vertical line across the 100 mm line. The distance (mm) between the endpoint \"no pain\" and the vertical line on the VAS was recorded and analysed., After 1 minute of each injection (Day 1)\n",
      "Sponsor: Novo Nordisk A/S\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE2\n",
      "Enrollment: 104.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients\n",
      "Brief Summary: This study is being carried out to see if dapagliflozin in addition to glimepiride (sulphonylurea) is effective and safe in treating patients with type 2 diabetes when compared to glimepiride alone.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DRUG: dapagliflozin|DRUG: Glimepiride|DRUG: metformin hydrochloride|DRUG: pioglitazone hydrochloride|DRUG: Rosiglitazone\n",
      "Primary Outcome Measure: Adjusted Mean Change in HbA1c Levels, To assess the efficacy of dapagliflozin compared to placebo as add-on therapy to glimepiride in improving glycemic control in participants with type 2 diabetes, as determined by the change in HbA1C levels from baseline to the end of the 24-week double-blind treatment period., Baseline to Week 24\n",
      "Sponsor: AstraZeneca\n",
      "Collaborators: Bristol-Myers Squibb\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 597.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Hypoglycemia in Hospitalized Patients\n",
      "Brief Summary: Patients with diabetes who develop low blood sugars (hypoglycemia) in the hospital are at risk for losing the ability to develop symptoms that warn them that they are having a low blood sugar. There is almost no available information investigating how the inability to feel symptoms of a low blood sugar contributes to the risk of this happening when people with diabetes are hospitalized. The purpose of this study is to develop a symptom score model that will help to identify patients at risk for low blood sugars in the hospital and to examine what happens to patients who do experience a low blood sugar in the hospital.\n",
      "Condition: Diabetes|Hypoglycemia\n",
      "Intervention: Unknown\n",
      "Primary Outcome Measure: Prevalence of Hypoglycemia Associated Autonomic Failure in the inpatient setting as assessed by hypoglycemia symptom scores, Hypoglycemia Symptom Score Questionnaires will be administered to participants in time frame described. These questionnaires include a list of potential autonomic and neuroglycopenic symptoms that can occur in response to hypoglycemia., Within 24-36 hours following a hypoglycemia event.\n",
      "Sponsor: University of Pittsburgh\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 58.0\n",
      "Funder Type: OTHER\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Performance of Six Equations for Estimating Resting Energy Expenditure in Patients With Type 2 Diabetes\n",
      "Brief Summary: The present study evaluated the statistical and clinical performance of the six common equations in subjects with type 2 diabetes adopting indirect calorimetry as reference standard\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: OTHER: Observational\n",
      "Primary Outcome Measure: Body weight, Body weight in Kilograms, Baseline|Neck circumference, Neck circumference in cm, Baseline|Waist circumference, Waist circumference in cm, At baseline|Hip circumference, Hip circumference in cm, Baseline|Body mass index (BMI), Body mass index (BMI) (expressed in kg/m\\^2), At baseline|Resting Energy Expenditure (REE), Resting Energy Expenditure (REE) in kcal, At baseline\n",
      "Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: CHILD, ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 250.0\n",
      "Funder Type: OTHER\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients\n",
      "Brief Summary: This study is to evaluate long-term safety and efficacy after concomitant administration of ASP1941 and α-glucosidase inhibitor in Japanese patients with type 2 diabetes mellitus.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: DRUG: ipragliflozin|DRUG: alpha glucosidase inhibitor\n",
      "Primary Outcome Measure: Change from baseline in HbA1c, baseline and 52 weeks\n",
      "Sponsor: Astellas Pharma Inc\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 113.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Gut Microbiota in Chronic Noncommunicable Diseases\n",
      "Brief Summary: It is an observational study in patients with chronic noncommunicable diseases (i.e. cardiovascular diseases, diabetes mellitus, non-alcoholic fatty liver disease, chronic obstructive pulmonary disease and asthma ) and control group with no signs of these conditions. The study has a prospective part planned for 2021 and a retrospective part which includes the patients enrolled between 2018-2020. The aim of the study is to investigate gut microbiota composition, its metabolites, levels of inflammatory and other markers of the disease in prospective groups (arterial hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, asthma, non-alcoholic fatty liver disease and control patients) as well as in retrospective groups (chronic heart failure with preserved and reduced ejection fraction, obstructive atherosclerosis of any vascular bed, arterial hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, asthma, non-alcoholic fatty liver disease, and control patients). Also we are planning to investigate the association between gut microbiota composition and its metabolites, levels of inflammatory and other markers of the disease in retrospective and prospective groups.\n",
      "Condition: Arterial Hypertension|Atherosclerosis Occlusive Disease|Heart Failure With Preserved Ejection Fraction|Heart Failure With Reduced Ejection Fraction|Diabetes Mellitus, Type 2|Obstructive Pulmonary Disease|Asthma|Nonalcoholic Fatty Liver Disease\n",
      "Intervention: Unknown\n",
      "Primary Outcome Measure: Significant (p<0,05) correlation (r>0,5) between abundance of Faecalibacterium genus and concentration of lipopolysaccharide, on enrollment\n",
      "Sponsor: National Medical Research Center for Therapy and Preventive Medicine\n",
      "Collaborators: Center for Strategic Planning and Management of Biomedical Health Risks of the Federal Biomedical Agency\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 1084.0\n",
      "Funder Type: OTHER_GOV\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Arginase Inhibition in Ischemia-reperfusion Injury\n",
      "Brief Summary: The present project is designed to test the hypothesis that arginase contributes to endothelial dysfunction induced by ischemia-reperfusion in patients with coronary artery disease.\n",
      "Condition: Coronary Artery Disease|Type 2 Diabetes Mellitus\n",
      "Intervention: DRUG: N-hydroxy-nor-arginine|DRUG: NaCl\n",
      "Primary Outcome Measure: Change in endothelial function, Flow-mediated dilatation of the radial artery, 20 min of reperfusion\n",
      "Sponsor: Karolinska Institutet\n",
      "Collaborators: Unknown\n",
      "Sex: MALE\n",
      "Age: CHILD, ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 24.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Comparison Chocolate With and Without High Cocoa Solids in Patients With Type 2 Diabetes in a Randomised Clinical Trial\n",
      "Brief Summary: Type 2 diabetes is being acknowledged as a potential public health time bomb, whose incidence is predicted to double over the next 10 years in the UK, associated with the rise in obesity and increasing sedentary lifestyles. Increased insulin resistance has been shown to be an important feature of type 2 diabetes (especially in those presenting with obesity and in particular visceral or abdominal obesity). Insulin resistance is implicated as a risk factor of cardiovascular disease and may lead to pancreatic dysfunction through increased β-cell stress in the pancreas. A combination of insulin resistance and pancreatic beta cell failure then leads to type 2 diabetes. The main cause of morbidity and mortality in type 2 diabetes is cardiovascular disease as the condition is associated with impaired vascular functioning and increased levels of oxidation markers.\n",
      "\n",
      "Epidemiological studies suggest dietary flavonoids decrease the risk of death from coronary heart disease, cancer, and stroke. Flavonoid-rich foods include fruits and vegetables as well as tea, red wine, and chocolate. In a cohort of elderly men, cocoa intake was inversely associated with blood pressure and 15-year cardiovascular and all-cause mortality. It has been reported that in healthy humans, consumption of flavanol-rich dark chocolate decreased daytime and night time blood pressure, reduced insulin resistance, and improved nitric oxide dependent vaso-relaxation. Another trial found that cocoa powder increased postprandial insulinaemia in lean young adults. These research papers have led to the hypothesis that chocolate containing high cocoa liquor may help to reduce the risk of developing type 2 diabetes.\n",
      "\n",
      "This study is design as a double-blind, controlled, single center, randomized, parallel design clinical trial. The primary outcome measure is to compare parameters of insulin resistance and glycaemic control in volunteers with type 2 diabetes after consumption of 3 different chocolates (one dark and two milk chocolates) with a secondary outcome of endothelial function, cholesterol profile and oxidative stress. Subjects will undergo medical screening, anthropometry, physical activity and dietary assessments before randomization.\n",
      "Condition: Diabetes Type 2\n",
      "Intervention: OTHER: Cocoa Polyphenols\n",
      "Primary Outcome Measure: Difference in Insulin Resistance (HOMA) Between Treatments After 12 Weeks of Product Intake, HbA1c with measurement of plasma glucose and insulin (to determine HOMA index) at the 84th day after product intake minus value at baseline (1st day of product intake. Insulin resistance is defined by a HOMA index \\> 2.4, 84th day of product intake\n",
      "Sponsor: Société des Produits Nestlé (SPN)\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 62.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Toujeo Versus NPH Self-titration Study\n",
      "Brief Summary: This is a 24 week, multicentre, prospective, randomized, controlled, parallel-designed (1:1) pilot study.The study will compare glycemic variability in patients treated with insulin glargine U300/ml insulin versus conventional (NPH) insulin using a self titration algorithm.50 type 2 diabetes patients who are newly started on insulin will be recruited. They will be randomly allocated to either insulin glargine U300 or NPH insulin for 26 weeks. All subjects will follow a insulin-self titration algorithm. The study will consist of 9 visits over 26 weeks. Blood glucose variability will be collected by CGM for 7 consecutive days at baseline (week -1) and at week 24.Secondary endpoints other than data on glycemic variability, including HbA1c, fasting plasma glucose, inflammatory markers will be measured during three periods (week 0, week 12 and week 24).\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: Insulin Glargine 300 UNT/ML|DRUG: Neutral protamine hagedorn insulin\n",
      "Primary Outcome Measure: Glycemic variability, Standard deviation of glucose from continuous glucose monitoring, 24 weeks\n",
      "Sponsor: Elaine Chow\n",
      "Collaborators: Sanofi\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE4\n",
      "Enrollment: 50.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002)\n",
      "Brief Summary: This study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of MK-8521.\n",
      "\n",
      "Part 1 primary hypothesis: Administration of single subcutaneous (SC) doses of MK-8521 is sufficiently safe and well- tolerated in healthy participants, based on assessment of clinical and laboratory adverse experiences, to permit continued clinical investigation.\n",
      "\n",
      "Part 2: Administration of multiple once daily SC doses of MK-8521 is sufficiently safe and well-tolerated in healthy lean and obese participants, based on assessment of clinical and laboratory adverse experiences, to permit continued clinical investigation.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: DRUG: MK-8521 35μg|DRUG: MK-8521 100μg|DRUG: MK-8521 125μg|DRUG: MK-8521 150μg|DRUG: MK-8521 175μg|DRUG: MK-8521 200μg|DRUG: MK-8521 300μg|DRUG: MK-8521 50/72μg|DRUG: MK-8521 72/125μg|DRUG: MK-8521 100/150μg|DRUG: MK-8521 125/150μg|DRUG: Placebo\n",
      "Primary Outcome Measure: Number of Participants Who Experienced at Least One Adverse Event (AE) (Part 1), An AE is defined as any untoward medical occurrence in a patient or clinical investigation participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding, for example), symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening (i.e., any clinically significant adverse change in frequency and/or intensity) of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE., From Day 1 through post-trial visit (Up to 8 weeks)|Number of Participants Who Discontinued Treatment Due to an AE (Part 1), An AE is defined as any untoward medical occurrence in a patient or clinical investigation participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding, for example), symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening (i.e., any clinically significant adverse change in frequency and/or intensity) of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE., Up to 8 weeks (Part 1)|Area Under the Concentration Time Curve of MK-8521 From 0 to Infinity (AUC0-∞) After a Single Dose (Part 1), AUC0-∞ is a measure of the mean concentration levels of drug in the plasma after the dose. A summary of pharmacokinetic parameters following administration of single SC (subcutaneous) injection of MK-8521 in healthy non-obese male participants (Part I, Panels A-B, Period 1-3 \\[100-300μg\\]) is presented. Method of dispersion is coefficient of variation (%CV). No pharmacokinetic analysis was performed on participants receiving Placebo., Pre-dose, 0.5, 1, 2, 4, 8, 10, 12, 14, 16, 24, 30, 34, 48, 72, 96, 120 hrs. post-dose (Part 1)|Peak Plasma Concentration (Cmax) of Participants Treated With a Single Dose of MK-8521 (Part 1), Cmax is a measure of the maximum amount of drug in the plasma after the dose is given. A summary of pharmacokinetic parameters following administration of single SC (subcutaneous) injection of MK-8521 in healthy non-obese male participants (Part I, Panels A-B, Period 1-3 \\[100-300μg\\]) is presented. Method of dispersion is coefficient of variation (%CV). No pharmacokinetic analysis was performed on participants receiving Placebo., Pre-dose, 0.5, 1, 2, 4, 8, 10, 12, 14, 16, 24, 30, 34, 48, 72, 96, 120 hrs. post-dose (Part 1)|Time Taken to Reach Cmax (Tmax) for Plasma Concentration of Participants Treated With a Single Dose of MK-8521 (Part 1), Tmax is a measure of the time to reach the maximum concentration in the plasma after the drug dose. A summary of pharmacokinetic parameters following administration of single SC (subcutaneous) injection of MK-8521 in healthy non-obese male participants (Part I, Panels A-B, Period 1-3 \\[100-300μg\\]) is presented. No pharmacokinetic analysis was performed on participants receiving Placebo., Pre-dose, 0.5, 1, 2, 4, 8, 10, 12, 14, 16, 24, 30, 34, 48, 72, 96, 120 hrs. post-dose (Part 1)|Apparent Terminal Half-life (t1/2) for Plasma Concentration of Participants Treated With a Single Dose of MK-8521 (Part 1), Apparent Terminal Half-life (t1/2) is the time required for a given drug concentration in the plasma to decrease by 50%. A summary of pharmacokinetic parameters following administration of single SC (subcutaneous) injection of MK-8521 in healthy non-obese male participants (Part I, Panels A-B, Period 1-3 \\[100-300μg\\]) is presented. Method of dispersion is coefficient of variation (%CV). No pharmacokinetic analysis was performed on participants receiving Placebo., Pre-dose, 0.5, 1, 2, 4, 8, 10, 12, 14, 16, 24, 30, 34, 48, 72, 96, 120 hrs. post-dose (Part 1)|Number of Participants With an Adverse Event (AE) (Part 2), An AE is defined as any untoward medical occurrence in a patient or clinical investigation participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding, for example), symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening (i.e., any clinically significant adverse change in frequency and/or intensity) of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE., From Day 1 through post-trial visit (Up to 7 weeks)|Number of Participants Who Discontinued Treatment Due to an AE (Part 2), An AE is defined as any untoward medical occurrence in a patient or clinical investigation participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding, for example), symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening (i.e., any clinically significant adverse change in frequency and/or intensity) of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE., Up to 7 weeks (Part 2)|AUC 0-24hr for Plasma Concentration of Participants Treated After Multiple Doses of MK-8521 (Part 2, Panels C, D, and E), AUC0-24hr is a measure of the mean concentration levels of drug in the plasma 0 to 24 hrs. after the dose. Mean pharmacokinetic parameter values for MK-8521 following administration of multiple subcutaneous once daily doses for 10 Days (with dose escalation on Day 5) to healthy non-obese male participants (Part II, Panel C, D, and E) are presented. Method of dispersion coefficient of variation (%CV). No pharmacokinetic analysis was performed on participants receiving Placebo. Blood collections for the determination of plasma MK-8521 concentrations were collected at the following time points for Part 2, Panel C, D, and E: Days 1, 4, 5, 9, 10 pre-dose; Days 1, 5, 10: 2, 4, 8, 10, 12, 16, 24 hrs. post dose; Day 10: 72, 96, 120 hrs. post-dose., Days 1, 5 and 10 (Part 2) (Panels C, D, E)|AUC 0-24hr for Plasma Concentration of Participants Treated After Multiple Doses of MK-8521 (Part 2, Panel F), AUC0-24hr is a measure of the mean concentration levels of drug in the plasma 0 to 24 hrs. after the dose. Mean pharmacokinetic parameter values for MK-8521 following administration of multiple subcutaneous once daily doses for 14 Days (with dose escalation on Day 7) to obese male participants (Part 2, Panel F) are presented. Method of dispersion coefficient of variation (%CV). No pharmacokinetic analysis was performed on participants receiving Placebo. Blood collections for the determination of plasma MK-8521 concentrations were collected at the following time points for Part 2, Panel F: Days 1, 3, 4, 5, 7, 9, 11, 13, 14 pre-dose; Days 1, 7, 14: 0.5, 1, 2, 4, 8, 10, 12, 14, 16, 24 hrs. post-dose; Day 14: 72, 96, 120 hrs. post-dose., Days 1, 7 and 14 (Part 2) (Panel F)|Cmax for Plasma Concentration of Participants Treated With Multiple Doses of MK-8521 (Part 2, Panels C, D, and E), Cmax is a measure of the maximum amount of drug in the plasma after the dose is given. Mean pharmacokinetic parameter values for MK-8521 following administration of multiple subcutaneous once daily doses for 10 Days (with dose escalation on Day 5) to healthy non-obese male participants (Part 2, Panel C, D, E and F) are presented. Method of dispersion is coefficient of variation (%CV). No pharmacokinetic analysis was performed on participants receiving Placebo. Blood collections for the determination of plasma MK-8521 concentrations were collected at the following time points for Part 2, Panel C-E: Days 1, 4, 5, 9, 10 pre-dose; Days 1, 5, 10: 2, 4, 8, 10, 12, 16, 24 hrs. post dose; Day 10: 72, 96, 120 hrs. post-dose., Days 1, 5 and 10 (Part 2) (Panels C, D, E)|Cmax for Plasma Concentration of Participants Treated With Multiple Doses of MK-8521 (Part 2, Panel F), AUC0-24hr is a measure of the mean concentration levels of drug in the plasma 0 to 24 hrs. after the dose. Mean pharmacokinetic parameter values for MK-8521 following administration of multiple subcutaneous once daily doses for 14 Days (with dose escalation on Day 7) to obese male participants (Part 2, Panel F) are presented. Method of dispersion coefficient of variation (%CV). No pharmacokinetic analysis was performed on participants receiving Placebo. Blood collections for the determination of plasma MK-8521 concentrations were collected at the following time points for Part 2, Panel F: Days 1, 3, 4, 5, 7, 9, 11, 13, 14 pre-dose; Days 1, 7, 14: 0.5, 1, 2, 4, 8, 10, 12, 14, 16, 24 hrs. post-dose; Day 14: 72, 96, 120 hrs. post-dose., Days 1, 7 and 14 (Part 2) (Panel F)|Trough Plasma Concentration (Ctrough) of Participants Treated With Multiple Doses of MK-8521 (Part 2, Panels C, D, and E), Trough plasma concentration (measured concentration at the end of a dosing interval at steady state \\[taken directly before next administration\\]). Mean pharmacokinetic parameter values for MK-8521 following administration of multiple subcutaneous once daily doses for 10 Days (with dose escalation on Day 5) to healthy non-obese male participants (Part 2, Panel C, D, and E) are presented. Method of dispersion is coefficient of variation (%CV). No pharmacokinetic analysis was performed on participants receiving Placebo. Blood collections for the determination of plasma MK-8521 concentrations were collected for Part 2, Panel C, D, and E: Days 1, 4, 5, 9, 10 pre-dose; Days 1, 5, 10: 2, 4, 8, 10, 12, 16, 24 hrs. post dose; Day 10: 72, 96, 120 hrs. post-dose., Days 1, 5 and 10 (Part 2) (Panels C, D, E)|Trough Plasma Concentration (Ctrough) of Participants Treated With Multiple Doses of MK-8521 (Part 2, Panel F), Trough plasma concentration (measured concentration at the end of a dosing interval at steady state \\[taken directly before next administration\\]). Mean pharmacokinetic parameter values for MK-8521 following administration of multiple subcutaneous once daily doses for 14 Days (with dose escalation on Day 7) to obese male participants (Part 2, Panel F) are presented. Method of dispersion is coefficient of variation (%CV). No pharmacokinetic analysis was performed on participants receiving Placebo. Blood collections for the determination of plasma MK-8521 concentrations were collected at the following time points for Part 2, Panel F: Days 1, 3, 4, 5, 7, 9, 11, 13, 14 pre-dose; Days 1, 7, 14: 0.5, 1, 2, 4, 8, 10, 12, 14, 16, 24 hrs. post-dose; Day 14: 72, 96, 120 hrs. post-dose., Days 1, 7 and 14 (Part 2) (Panel F)|Tmax for Plasma Concentration of Participants Treated With Multiple Doses of MK-8521 (Part 2, Panels C, D, and E), Tmax is a measure of the time to reach the maximum concentration in the plasma after the drug dose. Mean pharmacokinetic parameter values for MK-8521 following administration of multiple subcutaneous once daily doses for 10 Days (with dose escalation on Day 5) to healthy non-obese male participants (Part 2, Panel C, D, and E) are presented. Method of dispersion is coefficient of variation (%CV). No pharmacokinetic analysis was performed on participants receiving Placebo. Blood collections for the determination of plasma MK-8521 concentrations were collected at the following time points for Part 2, Panel C, D, and E: Days 1, 4, 5, 9, 10 pre-dose; Days 1, 5, 10: 2, 4, 8, 10, 12, 16, 24 hrs. post dose; Day 10: 72, 96, 120 hrs. post-dose., Days 1, 5 and 10 (Part 2) (Panels C, D, E)|Tmax for Plasma Concentration of Participants Treated With Multiple Doses of MK-8521 (Part 2, Panel F), Tmax is a measure of the time to reach the maximum concentration in the plasma after the drug dose. Mean pharmacokinetic parameter values for MK-8521 following administration of multiple subcutaneous once daily doses for 14 Days (with dose escalation on Day 7) to obese male participants (Part 2, Panel F) are presented. Mean pharmacokinetic parameter values for MK-8521 following administration of multiple subcutaneous once daily doses for 14 Days (with dose escalation on Day 7) to obese male participants (Part 2, Panel F) are presented. Method of dispersion is coefficient of variation (%CV). No pharmacokinetic analysis was performed on participants receiving Placebo. Blood collections occurred at the following time points for Part 2, Panel F: Days 1, 3, 4, 5, 7, 9, 11, 13, 14 pre-dose; Days 1, 7, 14: 0.5, 1, 2, 4, 8, 10, 12, 14, 16, 24 hrs. post-dose; Day 14: 72, 96, 120 hrs. post-dose., Days 1, 7 and 14 (Part 2) (Panel F)|Apparent Terminal Half-life (t1/2) for Plasma Concentration of Participants Treated With Multiple Doses of MK-8521 (Part 2, Part C, D, and E), Apparent Terminal Half-life (t1/2) is the time required for a given drug concentration in the plasma to decrease by 50%. Mean pharmacokinetic parameter values for MK-8521 following administration of multiple subcutaneous once daily doses for 10 Days (with dose escalation on Day 5) to healthy non-obese male participants (Part 2, Panel C, D, and E) are presented. Method of dispersion is coefficient of variation (%CV). Apparent terminal t1/2 was not reported for certain days since the terminal phase was not adequately captured with sampling up to 24hr post dose. No pharmacokinetic analysis was performed on participants receiving Placebo. Blood was collected for Part 2, Panel C, D, and E: Days 1, 4, 5, 9, 10 pre-dose; Days 1, 5, 10: 2, 4, 8, 10, 12, 16, 24 hrs. post dose; Day 10: 72, 96, 120 hrs. post-dose., Days 1, 5 and 10 (Part 2) (Panels C, D, E)|Apparent Terminal Half-life (t1/2) for Plasma Concentration of Participants Treated With Multiple Doses of MK-8521 (Part 2, Part F), Apparent Terminal Half-life (t1/2) is the time required for a given drug concentration in the plasma to decrease by 50%. Mean pharmacokinetic parameter values for MK-8521 following administration of multiple subcutaneous once daily doses for 14 Days (with dose escalation on Day 7) to obese male participants (Part 2, Panel F) are presented. Method of dispersion is coefficient of variation (%CV). Apparent terminal t1/2 was not reported for certain days since the terminal phase was not adequately captured with sampling up to 24hr post dose. No pharmacokinetic analysis was performed on participants receiving Placebo. Blood collections occurred at the following time points for Part 2, Panel F: Days 1, 3, 4, 5, 7, 9, 11, 13, 14 pre-dose; Days 1, 7, 14: 0.5, 1, 2, 4, 8, 10, 12, 14, 16, 24 hrs. post-dose; Day 14: 72, 96, 120 hrs. post-dose., Days 1, 7 and 14 (Part 2) (Panel F)|Number of Participants With an Adverse Event (AE) (Part 3), An AE is defined as any untoward medical occurrence in a patient or clinical investigation participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding, for example), symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening (i.e., any clinically significant adverse change in frequency and/or intensity) of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE., Up to 6 weeks (Part 3)|Number of Participants Who Discontinued Treatment Due to an AE (Part 3), An AE is defined as any untoward medical occurrence in a patient or clinical investigation participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding, for example), symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening (i.e., any clinically significant adverse change in frequency and/or intensity) of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE., Up to 6 weeks (Part 3)|Average Concentration (Cave) of MK-8521 Corresponding to Slope of Insulin Secretion Rate/Glucose (ISR/G) During Graded Glucose Infusion (GGI) at Tmax After a Single Dose of MK-8521 (Part 3), Pancreatic beta cell sensitivity to ambient glucose concentration after a single dose of MK-8521 125μg/35μg or placebo at Tmax was quantified as the slope of insulin secretion rate relative to glucose concentration (ISR/G) during GGI (160 minutes duration) and assessed against MK-8521 average plasma concentration (Cave) during the GGI to preliminarily characterize the PK/ pharmacodynamic (PD) relationship. Study drug was administered on Day -1. Plasma concentrations of MK-8521 were determined at -10 min pre-GGI and 40, 80, 120 \\& 160 min and blood concentrations of glucose, insulin \\& C-peptide were determined at -10, -5 (pre-GGI), 20, 40, 60, 80, 100, 120, 140 \\& 160 minutes after start of GGI on Day 1 of each period. ISR calculated by deconvolution of C-peptide concentrations using a two-compartmental model was regressed on glucose concentration via simple linear regression; beta cell glucose sensitivity was defined as slope from the regression line., From -10 to 160 minutes after GGI on Day 1 (Part 3)\n",
      "Sponsor: Merck Sharp & Dohme LLC\n",
      "Collaborators: Unknown\n",
      "Sex: MALE\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 61.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: An Artificial Intelligence Assisted Telehealth Intervention to Promote Self-Management in Patients With Type 2 Diabetes Mellitus (Qualitative Interview)\n",
      "Brief Summary: This protocol involves a qualitative study of the needs/preferences of people with diabetes and health coaches regarding a telehealth coaching platform for glycemic control in people with diabetes.\n",
      "Condition: Diabetes Mellitus\n",
      "Intervention: BEHAVIORAL: Semi-structured Interview\n",
      "Primary Outcome Measure: Users' Expectation from a Health Coaching System, This interview with participants help produce knowledge on the users' expectations from a health coaching system, 60 minutes\n",
      "Sponsor: University of Alabama at Birmingham\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 20.0\n",
      "Funder Type: OTHER\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia\n",
      "Brief Summary: This study is not being conducted in the United States. Key long-term clinical studies have shown that people with type 2 diabetes should try to achieve overall blood glucose levels as close to normal as possible. The purpose of this study is to gather data on the long-term safety and effectiveness of vildagliptin, an unapproved drug, compared to placebo in lowering overall blood glucose levels in people with type 2 diabetes who have not been previously treated with drug therapy to lower their blood sugar and whose blood glucose levels are close to normal.\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: Vildagliptin\n",
      "Primary Outcome Measure: Change from baseline in HbA1c at 108 weeks\n",
      "Sponsor: Novartis\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 150.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD\n",
      "Brief Summary: The purpose of this clinical research study is to determine whether dapagliflozin alone or in combination with saxagliptin can decrease albuminuria and improve glycemic control in patients with Type 2 diabetes, albuminuria and renal impairment (CKD). The study is planned to randomize a total of 450 patients (150 patients per treatment arm)\n",
      "Condition: Type 2 Diabetes Mellitus, CKD and Albuminuria\n",
      "Intervention: DRUG: Dapagliflozin 10 mg|DRUG: Saxagliptin 2.5 mg|DRUG: Matching Placebo for Dapagliflozin 10 mg and Saxagliptin 2.5mg\n",
      "Primary Outcome Measure: Adjusted Mean Change From Baseline in Glycosylated Haemoglobin (HbA1c): Comparison of Dapagliflozin 10 mg Plus Saxagliptin 2.5 mg and Placebo at Week 24, HbA1c was analysed at baseline and every 4 weeks during the 24-week treatment period. Only measurements prior to rescue or treatment discontinuation were analysed. The adjusted mean change from baseline at Week 24 was analysed using a mixed model repeated measures (MMRM) model., Baseline and Week 24|Adjusted Mean Percent Change From Baseline in Urine Albumin-to-Creatinine Ratio (UACR) at Week 24, UACR was analysed at baseline and every 4 weeks during the 24-week treatment period. All measurements regardless of rescue medication or treatment discontinuation were analysed. UACR values were first transformed to logarithms and the results were based on exponentiation of model estimates and expressed as adjusted mean percent change from baseline at Week 24., Baseline and Week 24\n",
      "Sponsor: AstraZeneca\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE2|PHASE3\n",
      "Enrollment: 459.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Hypoglycemia Biomarkers to Predict Timing of a Hypoglycemic Event\n",
      "Brief Summary: The study aims to obtain a panel of biomarkers from hypoglycemic diabetic patients with either type 1 or type 2 diabetics and from control patients with type 1 or type 2 diabetes who didn't have hypoglycemia in the last 72 hours.\n",
      "Condition: Hypoglycemia\n",
      "Intervention: Unknown\n",
      "Primary Outcome Measure: Concentrations of a Panel of Protein Biomarkers in hypoglycemic subjects, a panel of biomarkers is measured from a blood test taken during the incidence of hypoglycemia from type 1 or type 2 Diabetic subject., 1 day from time of presentation\n",
      "Sponsor: Royal College of Surgeons in Ireland - Medical University of Bahrain\n",
      "Collaborators: King Hamad University Hospital, Bahrain\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 150.0\n",
      "Funder Type: OTHER\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Study to Observe How Insulin Glargine 300 U/ml is Working and is Tolerated in Elderly Patients ≥75 Years of Age With Type 2 Diabetes\n",
      "Brief Summary: Primary objective:\n",
      "\n",
      "- Glycemic control after initiation or switch to insulin glargine 300 U/ml in everyday clinical practice\n",
      "\n",
      "Secondary objective:\n",
      "\n",
      "- Treatment satisfaction\n",
      "Condition: Type 2 Diabetes Mellitus (T2DM)\n",
      "Intervention: Unknown\n",
      "Primary Outcome Measure: Proportion of participants achieving the HbA1c target value, Proportion of participants achieving their individual HbA1c target value (pre-defined by the treating physician) within 6 months of initiation or switch to insulin glargine 300 U/ml, 6 months\n",
      "Sponsor: Sanofi\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 82.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)\n",
      "Brief Summary: Mild Cognitive Impairment (MCI) represents a group of persons who are at risk of incident dementia in the near-term. Persons with MCI who have deficits in short-term recall (amnestic MCI) are at significant risk of incident Alzheimer's disease (AD) (termed prodromal AD), and thus represent a worthy target for secondary prevention interventions.\n",
      "\n",
      "There is increasing evidence that risk factors for metabolic syndrome (such as prediabetes and type 2 diabetes) increase risk of incident cognitive impairment and possibly AD, and evidence that the neurons of the AD brain are in fact insulin resistant with diminished glucose uptake under physiological conditions. Thus, persons with MCI and prediabetes or type 2 diabetes may be at particular risk of incident cognitive impairment and AD.\n",
      "\n",
      "A large clinical trial (ACCORD)1 demonstrated that tight control of peripheral blood glucose does not improve cognitive (or other health) outcomes in older persons with peripheral insulin resistance. Thus, there is a need to target cognitive outcomes in persons with MCI and metabolic risk factors, and a drug targeting insulin resistance with good blood-brain-barrier (BBB) penetrance can potentially accomplish these objectives. While there is a phase III study of intranasal insulin targeting this strategy, nutraceuticals offer a low-tech solution that would be more suitable to future secondary prevention trials in MCI.\n",
      "\n",
      "Bioactive Dietary Polyphenol Preparation (BDPP) is a combination of two nutraceutical preparations grape seed polyphenolic extract (GSE), and resveratrol that contain abundant concentrations of polyphenols. The investigators have found that oral BDPP administration was associated with improved cognition and brain plasticity long-term potentiation (LTP) in mouse models of metabolic syndrome and AD, as well as lowering brain amyloid and tau burden in an AD mouse model2-4. The investigators have demonstrated excellent absorption of oral BDPP in a small study in humans and similarly excellent CSF penetration of oral BDPP in rats, but it is crucial to demonstrate safety and CSF penetration of oral BDPP in humans to assess its potential as a treatment for MCI and prediabetes or type 2 diabetes.\n",
      "Condition: Mild Cognitive Impairment|Alzheimer's Disease\n",
      "Intervention: DRUG: grape seed polyphenolic extract, resveratrol\n",
      "Primary Outcome Measure: Assessment of Adverse Events (AEs) and Serious Adverse Events (SAEs), 4 months|Confirm brain penetrance of BDPP by measuring levels of BDPP constituents in cerebrospinal fluid (CSF)., 4 months|Evaluate BDPP effect on mood with Neuropsychiatric Inventory and Cornell Scale for Depression in Dementia., 4 months|Evaluate BDPP effect on cognition with measures of memory, executive function, and attention measures (composite), 4 months\n",
      "Sponsor: Johns Hopkins University\n",
      "Collaborators: Icahn School of Medicine at Mount Sinai\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 14.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Inulin,SCFA Production and Metabolic Response\n",
      "Brief Summary: In this placebo controlled, double-blind, randomized crossover study the investigators will investigate in overweight/obese healthy male volunteers whether inulin administration will increase intestinal SCFA production, thereby investigating whether this will lead to acute metabolic effects.\n",
      "Condition: Type 2 Diabetes Mellitus|Obesity\n",
      "Intervention: DIETARY_SUPPLEMENT: 13C inulin|OTHER: Placebo\n",
      "Primary Outcome Measure: Fat oxidation, energy expenditure, Fat oxidation and energy expenditure are measured after inulin ingestion, 1 study day for each administration\n",
      "Sponsor: Maastricht University Medical Center\n",
      "Collaborators: Top Institute Food and Nutrition\n",
      "Sex: MALE\n",
      "Age: ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 15.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Ischemic Preconditioning and Type 2 Diabetes\n",
      "Brief Summary: The aim of this study is to determine the impact of 7 days of daily ischemic preconditioning (IPC) on vascular function and insulin sensitivity in Type 2 Diabetes Mellitus.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: OTHER: Ischemic Preconditioning\n",
      "Primary Outcome Measure: Changes in vascular function, Vascular function will be measured via endothelial-dependent flow-mediated dilation (FMD) of the brachial and femoral arteries and reported as percentage change., Change from before the intervention, to immediately following the intervention, to 8 days following the end of the intervention\n",
      "Sponsor: Liverpool John Moores University\n",
      "Collaborators: Liverpool University Hospitals NHS Foundation Trust\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 21.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes\n",
      "Brief Summary: This study was not conducted in the United States. Many people with type 2 diabetes also have high cholesterol levels. The purpose of this study was to evaluate the effects of vildagliptin, an unapproved drug, on blood lipid measures such as triglycerides and cholesterol in people with type 2 diabetes.\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: vildagliptin\n",
      "Primary Outcome Measure: Postprandial serum total triglycerides at 4 weeks\n",
      "Sponsor: Novartis Pharmaceuticals\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE2\n",
      "Enrollment: 38.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Study Of PF-05175157 In Healthy Volunteers\n",
      "Brief Summary: The primary purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of single oral doses of PF-05175157 in healthy volunteers.\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: PF-05175157 or Placebo|DRUG: PF-05175157 or Placebo|DRUG: PF-05175157 or Placebo|DRUG: PF-05175157 or Placebo|DRUG: PF-05175157 or Placebo|DRUG: PF-05175157 or Placebo|DRUG: PF-05175157 or Placebo\n",
      "Primary Outcome Measure: Safety and tolerability of escalating single doses of PF-05175157 in healthy subjects, 5 months|Single dose pharmacokinetics of PF-05175157, 5 months\n",
      "Sponsor: Pfizer\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 63.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes\n",
      "Brief Summary: The purposes of this study are to determine:\n",
      "\n",
      "* The safety of tirzepatide and any side effects that might be associated with it.\n",
      "* How much tirzepatide gets into the bloodstream and how long it takes the body to remove it.\n",
      "* How tirzepatide affects the levels of blood sugar.\n",
      "\n",
      "This study includes eight weekly doses of tirzepatide or placebo given as subcutaneous (SC) injections just under the skin. The study will last about 16 weeks (total), including screening and follow-up. This study is for research purposes only and is not intended to treat any medical conditions.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: DRUG: Tirzepatide|DRUG: Placebo\n",
      "Primary Outcome Measure: Number of Participants With One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration, Safety was assessed from time of consent through end of study (up to 85 days). Data presented are the number of participants who experienced 1 or more SAEs considered by the investigator to be related to study drug. A summary of SAEs and other non-serious AEs, regardless of causality is located in the Reported Adverse Events section of this record., Baseline through Day 85\n",
      "Sponsor: Eli Lilly and Company\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 48.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes\n",
      "Brief Summary: The purpose of this study is to determine whether pioglitazone, once daily (QD), can delay the time to death, heart attack, acute coronary syndrome, heart bypass surgery, stroke, leg bypass surgery or amputation in patients with type 2 diabetes.\n",
      "Condition: Diabetes Mellitus\n",
      "Intervention: DRUG: Pioglitazone|DRUG: Placebo\n",
      "Primary Outcome Measure: Time to the Composite of All Cause Mortality, Non-Fatal Myocardial Infarction, Stroke, Acute Coronary Syndrome, Major Leg Amputation, Cardiac Intervention, Bypass Surgery or Leg Revascularization., At First Occurrence\n",
      "Sponsor: Takeda\n",
      "Collaborators: Eli Lilly and Company\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 4373.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Dose Ranging Study With LT, Monotherapy, PPAR\n",
      "Brief Summary: A Randomized, Double-Blind, Dose-Ranging, Dose Comparison-Controlled Trial to Determine the Safety and Efficacy of BMS-298585 in Subjects with Type 2 Diabetes\n",
      "Condition: Diabetes Mellitus II\n",
      "Intervention: DRUG: Muraglitazar\n",
      "Primary Outcome Measure: To compare, after 24 weeks of oral administration of double-blind treatment, the change from baseline in hemoglobin A1c (HbA1c) achieved with the highest dose and subsequent doses of BMS-298585 versus the lowest dose of BMS-298585 in subjects with Type 2\n",
      "Sponsor: Bristol-Myers Squibb\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE2|PHASE3\n",
      "Enrollment: 1260.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: T2DM Intensity Lifestyle Intervention\n",
      "Brief Summary: This RCT study will evaluate the effect of a lifestyle intervention on overweight or obese patients with type 2 diabetes mellitus. The primary hypothesis is that the mHealth-based intensive lifestyle intervention is sufficient to achieve weight loss and maintain glycated hemoglobin control.\n",
      "Condition: Diabetes Mellitus, Type 2|Overweight or Obesity\n",
      "Intervention: BEHAVIORAL: lifestyle intervention\n",
      "Primary Outcome Measure: Weight change from baseline, measured in kilograms (kg) and calculate the change percentage(%), at end of the 3-month intervention|The change of HbA1c from baseline, measured in percent (%), at end of the 3-month intervention\n",
      "Sponsor: Ningbo No. 1 Hospital\n",
      "Collaborators: Peking University\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 120.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Online Diabetes Education Project (ODEP)\n",
      "Brief Summary: This pilot randomized control trial will be testing an empowerment-based virtual group diabetes self-management education and support (DSME/S) for African American/Black adults with type 2 diabetes living in Detroit. Participants will be randomized to either a control group or the virtual DSME/S group.\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: BEHAVIORAL: Virtual Diabetes Self-Management Education and Support\n",
      "Primary Outcome Measure: Metabolic Control of A1c (Mean Change in A1C), Measured using the DCA 2000 point-of-care testing instrument. The American Diabetes Association recommends people living with diabetes to have an A1C below 7.0%., baseline and at 3 months|Depression, Measured using the Patient Health Questionnaire (PHQ-9). A PHQ-9 score of 0-4 means none-minimal depression severity, a score of 5-9 means mild depression severity, a score of 10-14 means moderate depression severity, a score of 15-19 means moderately severe depression, and 20-27 means severe depression., baseline and at 3 months|Regimen Adherence, Measured using the Perceived Diabetes Self-Management Scale (PDSMS), a self-report questionnaire used to measure a broad range of management behaviors, such as insulin management, dietary management, blood glucose monitoring, symptom response, and parent assistance/supervision. The total PDSMS score can range from 8 to 40, with higher scores indicating more confidence in self-managing one's diabetes. For this study, we reported mean change in PDSMS score., baseline and at 3 months\n",
      "Sponsor: University of Michigan\n",
      "Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 12.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: ENCOMPASS: Expansion Study A, RCT\n",
      "Brief Summary: Some patients living with multiple long-term health conditions have difficulty accessing the services they need, despite available primary care and community resources. Patient navigation programs may help those with complex health conditions to improve their care and outcomes. Community health navigators (CHNs) are community members who help guide patients through the health care system. CHNs are not health professionals like a doctor or nurse, but they are specially trained to help patients get the most out of their health care and connect them to resources. The ENCOMPASS program of research evaluates a patient navigation program that connects patients living with long-term health conditions to CHNs. To understand if the CHN program can be scaled to a provincial level, the ENCOMPASS program of research is expanding to select primary care settings across Alberta. This study implements and evaluates the CHN program at Edmonton Oliver Primary Care Network in Edmonton, Alberta, Canada.\n",
      "Condition: Hypertension|Diabetes Mellitus, Type 2|Chronic Kidney Diseases|Ischemic Heart Disease|Congestive Heart Failure|Chronic Obstructive Pulmonary Disease|Asthma\n",
      "Intervention: BEHAVIORAL: Community Health Navigator Program\n",
      "Primary Outcome Measure: Acute care service use, Rate of emergency department visits and hospital admissions based on administrative health data., Up to 36 months\n",
      "Sponsor: University of Calgary\n",
      "Collaborators: University of Alberta\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 96.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)\n",
      "Brief Summary: Growing evidence over recent years supports a potential role for low grade chronic inflammation in the pathogenesis of insulin resistance and type 2 diabetes. In this study we will determine whether salsalate, a member of the commonly used Non-Steroidal Anti-Inflammatory Drug (NSAID) class, is effective in lowering sugars in patients with type 2 diabetes. The study will determine whether salicylates represent a new pharmacological option for diabetes management. The study is conducted in two stages. The first stage is a dose ranging study, administering salsalate compared to placebo over three months. The primary objective of Stage 2 of the study is to evaluate the effects of salsalate on blood sugar control in diabetes; the tolerability of salsalate use in patients with type 2 diabetes (T2D); and the effects of salsalate on measures of inflammation, the metabolic syndrome, and cardiac risk.\n",
      "\n",
      "The second stage is a second trial and posted under alternate registration.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DRUG: Salsalate|DRUG: Placebo\n",
      "Primary Outcome Measure: Change in HbA1c Baseline to End of Trial in TINSAL-T2D Stage 1, The primary outcome for the TINSAL-T2D study is change in HbA1c level from baseline to week 14 (stage 1) in the intent-to-treat (ITT) population with last observation carried forward., 14 week\n",
      "Sponsor: Joslin Diabetes Center\n",
      "Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE2|PHASE3\n",
      "Enrollment: 277.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients\n",
      "Brief Summary: This study will evaluate the pharmacokinetics of vildagliptin (LAF237) and its metabolites in patients with mild renal impairment compared to their sex, age and weigh based healthy volunteer counterparts.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: DRUG: vildagliptin\n",
      "Primary Outcome Measure: Pharmacokinetic measures, throughout the study\n",
      "Sponsor: Novartis\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 29.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Cost Effectiveness of Glargine Insulin Versus NPH Insulin\n",
      "Brief Summary: Glycemic control is fundamental in the management of diabetes mellitus .If lifestyle intervention and full tolerated doses of one or two oral glucose lowering drugs (OGLDs) fail to achieve or sustain glycemic goals, insulin should be initiated. New insulin analogs are generated to improve glycemic control .New insulin analogs are generated to improve glycemic control,However, the cost of these analogs is a major problem .The aim of this piggy back evaluation was to assess the effect of Glargine insuline versus NPH plus regular human insulin on metabolic control as well as its cost-effectiveness in people with type 2 diabetes in the Iranian setting.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: DRUG: insulin glargine|DRUG: Insulin NPH\n",
      "Primary Outcome Measure: Number Of Hypoglycemic events, The Number Of Hypoglycemic Events That Happend For Patients During Taking Both Insulines, 3 months\n",
      "Sponsor: Tehran University of Medical Sciences\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE4\n",
      "Enrollment: 200.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: BASIC_SCIENCE\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics\n",
      "Brief Summary: The purpose of this study is to evaluate the efficacy and safety of VI-0521 compared to placebo in the glycemic management of obese diabetic adults.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: DRUG: VI-0521|DRUG: Placebo\n",
      "Primary Outcome Measure: Change From Baseline in HbA1c at Week 28., Baseline to 28 weeks\n",
      "Sponsor: VIVUS LLC\n",
      "Collaborators: Synteract, Inc.\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE2\n",
      "Enrollment: 210.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: The Effect of Supplementation With Two Different Doses of Vitamin D on Bone Mineral Density, Vitamin D Levels and Hand Grip Strength in Children With Diabetes Mellitus Type 1\n",
      "Brief Summary: The aim of the study is to assess the effect of 12 month supplementation with two different doses of vitamin D ( 500 vs 1000) on bone mineral density, serum 25 hydroxyvitamin D levels and hand grip strength in preadolescents with diabetes mellitus type 1.\n",
      "\n",
      "100 children in the of age 8 -11 with diabetes mellitus type 1 lasting for more than 3 months, without history of diabetic ketoacidosis during previous month, without other chronic disease which may affect calcium-phosphorus metabolism will be randomized in a double blind controlled trial to supplement them with either 500 IU or 1000 IU vitamin D. Every 3 months, in spring summer,autumn and winter serum level of calcium,25-hydroxyvitamin D level and HbA1c will be measured. At the entry and at the end of the study patients will have total body and lumbar spine bone mineral density assessment. Every six months hand grip strength will be measured. Additionally at the beginning and after 12 mo of supplementation and at the beginning serum levels of TNF-alfa, osteoprotegerin and IL-6 will be assessed.\n",
      "Condition: Diabetes Mellitus Type 1\n",
      "Intervention: DRUG: Vitamin D3|DRUG: Vitamin D3\n",
      "Primary Outcome Measure: Percentage of patients with normal bone mineral density (z-score>-1)at lumbar spine(L2-L4)and total body after 12mo of supplementation, Bone mineral density will be assessed with DEXA (dual energy X ray absorptiometry)method at the beginning of the study and after 12 month of supplementation with vitamin D, 12 month|Percentage of patients with adequate 25 hydroxyvitamin level ( >50 ng/ml), every 3 month in spring summer autumn and winter each patient will have blood testing for the serum level of 25hydroxyvitamin D., 12 month|Mean bone mineral density z-score (L2-L4, total body) after 12 mo of supplementation, Bone mineral density will be assessed with DEXA (dual energy X ray absorptiometry)method at the beginning of the study and after 12 month of supplementation with vitamin D, 12 month|Mean isometric hand grip force, assessed at 6 and 12 mo of supplementation, 12 month\n",
      "Sponsor: Medical University of Warsaw\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: CHILD\n",
      "Phase: PHASE4\n",
      "Enrollment: 60.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Shared Decision Making Between Patients and GPs in the Treatment of Type 2 Diabetes in Primary Care.\n",
      "Brief Summary: Background: Less than 20% of type 2 diabetes mellitus (T2DM) patients in different healthcare settings achieve all treatment goals to prevent cardiometabolic disease. A more personalised approach with shared decision making should increase that percentage. Because the ADDITION-Europe study demonstrated two (almost) equally effective treatments but with slightly different intensities, it may be a good starting point to discuss with the patients their diabetes treatment, taking into account both the intensity of treatment, clinical factors and patients' preferences. The aim of the study was to evaluate whether such an approach increases the proportion of treatment goals that T2DM patients achieve.\n",
      "\n",
      "Methods: In a cluster-randomised trial in 40 primary care practices that participated until 2009 in the ADDITION Study, 150 T2DM patients 60 - 80 years, known with T2DM for 8-15 years, will be included. Practices are randomised a second time, i.e. intervention practices in the ADDITION study could be control practices in the current study and vice versa. For the GPs from the intervention group a 2-hour training in shared decision making (SDM) was developed as well as a decision support tool to use during the consultation. These GPs plan the first visit with the patients to decide on the intensity of the treatment, personalised targets and the priorities of treatment. The control group will continue with the treatment they were allocated to in the ADDITION study (treatment-as-before). Follow-up: 24 months. The primary outcome is the proportion of patients who achieve all three treatment goals (HbA1c, blood pressure, total cholesterol) at 24 months. Secondary outcomes are the proportion of patients who achieve five treatment goals (HbA1c, blood pressure, total cholesterol , body weight, not smoking), evaluation of the SDM process (SDM-Q9), satisfaction with the treatment (DTSQ), wellbeing and quality of life (W-BQ12, ADD QoL-19), health status (SF-36, EQ-5D) and coping (DCMQ). The proportions of achieved treatment goals will be compared between groups by estimating the relative risk of meeting the treatment targets. For the secondary outcomes mixed models will be used.\n",
      "\n",
      "Discussion: To achieve optimal diabetes care with a higher proportion of achieved individualised treatment goals, the SDM approach including a multi-faceted decision support tool might be useful. An intervention with such a support decision tool is designed.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: BEHAVIORAL: Shared decision making\n",
      "Primary Outcome Measure: The between groups difference in the proportion of patients which achieve the treatment goals for HbA1c, blood pressure, and total cholesterol, The proportions of achieved treatment goals of HbA1c, blood pressure, total cholesterol within each study group will by estimated by calculating relative risk. Intention-to-treat analyses (ITT) will be performed to examine between-group differences., after 12 months\n",
      "Sponsor: UMC Utrecht\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 153.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood Glucose\n",
      "Brief Summary: The procurement of blood for SMBG, usually via a finger stick, is considered by many patients to be the most painful portion of diabetes therapy. This has led to the marketing of smaller gauge lancets, lancing devices with variable depth settings and blood glucose sensors that require less blood for measurement.\n",
      "\n",
      "In this study, two main outcomes were evaluated: The first, which was assessed at Visit 1, was whether specific combinations of lancets and lancing devices would yield sufficient blood volume to allow valid assessment of diabetic subjects' glucose levels. The other outcome, assessed at Visit 2, was the level of pain perceived by subjects during lancing with specific combinations of lancets and lancing devices. During Visit 2, pain assessment was done using a Visual Analog Scale and such that for each lancet/lancing device, the lowest lancing device setting that yielded a valid BG reading for each subject during Visit 1 was used. A third outcome measure, overall comfort with lancing, was also assessed at Visit 2.\n",
      "\n",
      "A total of 5 combinations of lancets and lancing devices were evaluated.\n",
      "\n",
      "These were as follows:\n",
      "\n",
      "* BD/33G = BD Lancet device/BD 33G lancets (BGM measured with the OneTouch® UltraMini™ (BGM) and OneTouch® Ultra® test strips)\n",
      "* OTM/33G =OneTouch® Mini Lancet device / BD 33G lancet (BGM measured with the OneTouch® UltraMini™ (BGM) and OneTouch® Ultra® test strips)\n",
      "* OTM/28G =OneTouch® Mini Lancet device / OneTouch® UltraSoft® 28G Lancet (BGM measured with the OneTouch® UltraMini™ (BGM) and OneTouch® Ultra® test strips)\n",
      "* OTU/28G = OneTouch® UltraSoft® Lancet device/OneTouch® UltraSoft® 28G Lancet (BGM measured with the OneTouch® UltraMini™ (BGM) and OneTouch® Ultra® test strips)\n",
      "* ACC/28G= Accu-Chek® Softclix Lancet device/Accu-Chek® Softclix 28G Lancet (BGM measured with Accu-Chek® Advantage BGM and Accu-Chek® Comfort Curve test strip)\n",
      "\n",
      "After enrollment and qualification, subjects were assigned to one of 4 intervention arms. The arm assignment determined which 3 of the 5 combinations of lancets and lancing devices the subjects would evaluate in Visit 1 (for volume adequacy) and of these 3, which 2 they would evaluate in Visit 2 (pain during lancing). The lancet/lancing device combinations assigned to each arm are shown in the Assigned Interventions Table below.\n",
      "Condition: Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2\n",
      "Intervention: DEVICE: BD/33G|DEVICE: OTM / 33G|DEVICE: OTU/28G|DEVICE: ACC/28G|DEVICE: OTM/28G\n",
      "Primary Outcome Measure: Blood Sample of Sufficient Volume to Yield a Valid Meter Reading, Number of subjects in whom valid meter reading was obtained with each device configuration. The primary outcome of a successful lancing is defined as whether or not a technician is able to use the lancing system to yield a blood sample of sufficient volume to yield a valid meter reading., Study Day 1 (Visit 1)|Difference in Lancing Pain for Device Pair at Visit 2. (For Subjects Assigned to Arms A, B, C Only), In Visit 2 subjects kept the same group assignment they had in Visit 1. Each subject tested 2 of the 3 systems from Visit 1. Up to 6 pairs of lancings were performed in order to obtain 4 evaluable pairs. After each pair of lancing, the subject was asked to record the pain from the 2nd lancing as compared to the first using a 150mm visual analog scale(0mm = same pain, -75mm = max score for less painful than first lancing,+75mm = max score for more painful). A positive value on the scale (and in table below) indicates that the first device in the pair was more painful than the second., Approximately Day 3 (Visit 2)\n",
      "Sponsor: Becton, Dickinson and Company\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 250.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: \n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus\n",
      "Brief Summary: To introduce initiation of glargine insulin treatment in primary care based on a patient education program. To show and compare feasibility of group education to individual education program.\n",
      "Condition: Diabetes Mellitus\n",
      "Intervention: DRUG: Insulin Glargine\n",
      "Primary Outcome Measure: Superiority is based on observing clinically significant difference in glycaemic control (> than or = to 0,5 % HbA1c). Programs are defined as equally successful if the HbA1c differs less than 0,5 %., HbA1c values at visits 1, 2, 5 and 10\n",
      "Sponsor: Sanofi\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE4\n",
      "Enrollment: 124.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Surgery Or Lifestyle Intervention for Type 2 Diabetes (SOLID)\n",
      "Brief Summary: This research study will investigate the safety and effectiveness of weight loss surgery for overweight persons with type 2 diabetes. Eligible patients will undergo one of 2 types of weight loss surgery, Roux-en-Y gastric bypass, or laparoscopic adjustable gastric banding, or an intensive lifestyle modification. Participants will be closely followed for one year to compare the effects of these treatments on diabetes remission.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: PROCEDURE: Roux-en-Y Gastric Bypass surgery|PROCEDURE: Laparoscopic Adjustable Gastric Banding surgery|BEHAVIORAL: Intensive Lifestyle Modification\n",
      "Primary Outcome Measure: The primary objective of this study is to compare the rates of diabetes remission over one year., One year\n",
      "Sponsor: University of Pennsylvania\n",
      "Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 7.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Comparison of Th1 Cytokine Levels Between Type 1 and Type 2 Diabetes\n",
      "Brief Summary: Recent reports show increased prevalence of obesity in patients with type 1 diabetes (T1DP)s while some studies stated that patients with type 2 diabetes (T2DPs) have islet cell auto-antibodies. These results raise the question of a common pathway in T1DM and T2DM via an association with T helper cells. In this study investigators aimed to investigate the difference between T helper 1 (Th1) cytokines levels in T1DPs, T2DPs and healthy subjects.\n",
      "\n",
      "The study included 114 T1DPs on insulin treatment, 35 newly diagnosed T2DPs who had not used oral antidiabetics but insulin before and 31 healthy subjects (CG).\n",
      "\n",
      "Serum interferon gamma (IFN-γ), interleukin-2 (IL-2) and tumor necrosis factor alpha (TNF-α) levels were measured using ELISA method. Serum levels of those cytokines in T1DPs were compared with those in T2DPs and controls.\n",
      "Condition: Type 1 Diabetes|Type 2 Diabetes\n",
      "Intervention: Unknown\n",
      "Primary Outcome Measure: Difference in T helper cytokines between groups, 6 months\n",
      "Sponsor: Istanbul Medeniyet University\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 180.0\n",
      "Funder Type: OTHER\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin\n",
      "Brief Summary: In this study the effect of ipragliflozin on glucose homeostasis in healthy subjects and T2DM subjects, and the effect of exposure of ipragliflozin on urinary glucose excretion and plasma glucose in T2DM subjects will be investigated.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: DRUG: ASP1941|DRUG: Placebo\n",
      "Primary Outcome Measure: Part A: Assessment of glucose homeostasis in fasted condition and after an oral glucose load, following multiple doses of ipragliflozin in healthy subjects and subjects with T2DM, 4 days|Part A: Assessment of peripheral glucose utilization after an oral glucose load, following multiple doses of ipragliflozin, 4 days|Part A: Assessment of splanchnic uptake after an oral glucose load, following multiple doses of ipragliflozin, 4 days|Part A: Assessment of mean glucose levels in fasted condition and after an oral glucose load, following multiple doses of ipragliflozin, 4 days|Part B: Assessment of the relationship between the exposure to ipragliflozin in plasma, urinary glucose excretion and plasma glucose levels in subjects with T2DM, 6 days (PK), 12 days (urine) and 8 days (PD)\n",
      "Sponsor: Astellas Pharma Europe B.V.\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 44.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Comparison Between Enlite and Flash Glucose Monitoring\n",
      "Brief Summary: 1. The accuracy of the sensors (Flash vs Enlite glucose monitoring) will be evaluated with a standardized breakfast test. Patients receive a standardized breakfast. The usual insulin bolus will be administered at breakfast. After breakfast, a venous blood sample is taken for 2 hours every 15 minutes to determine the blood sugar. At the same time, the glucose value shown by the sensors will be noted. A comparison of the blood glucose value with the data recorded by the sensor can evaluate the accuracy of the sensor and also estimate the lag-time between the sensor glucose and the venous glucose.\n",
      "2. Patient satisfaction will be evaluated using a questionnaire that will be completed after the Enlite sensor has been worn for 1 month.\n",
      "3. The development of skin reactions will be checked by a short questionnaire, supplemented with a picture of possible skin phenomena.\n",
      "4. The data recorded by the FreeStyle sensor (average glucose,% above target,% within target,% under target, amount of hypoglycemia) in the month prior to sensor switching will be compared to the same data recorded by the Enlite sensor during the first month of use.\n",
      "Condition: Type1 Diabetes Mellitus\n",
      "Intervention: DEVICE: Enlite sensor communicating with Minimed 640G pump\n",
      "Primary Outcome Measure: Accuracy of Enlite sensor, The accuracy of the sensors (flash vs enlite glucose monitoring) will be evaluated with a standardized breakfast test. Patients receive a standardized breakfast. The usual insulin bolus will be administered at breakfast. After breakfast, a venous blood sample is taken for 2 hours every 15 minutes to determine the blood sugar. At the same time, the glucose value shown by the sensors will be noted. A comparison of the blood glucose value with the data recorded by the sensor can evaluate the accuracy of the sensor and also estimate the lag-time between the sensor glucose and the venous glucose., 2 hours\n",
      "Sponsor: Jessa Hospital\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: CHILD, ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 20.0\n",
      "Funder Type: OTHER\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes\n",
      "Brief Summary: The purpose of this study is to find out if treatment with degludec insulin when compared to glargine U100 insulin will result in similar blood sugar control in patients with diabetes who are admitted to the hospital and then transition to home after discharge from the hospital.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DRUG: Degludec|DRUG: Glargine|DRUG: Aspart\n",
      "Primary Outcome Measure: Mean Daily Blood Glucose Concentration in Hospitalized Patients, Blood glucose was measured before each meal and at bedtime among hospitalized study participants. Mean daily blood glucose concentration was calculated to determine differences in inpatient glycemic control in general medicine and surgery patients with Type 2 Diabetes (T2D) treated with basal bolus regimen with insulin degludec or glargine once daily plus aspart insulin before meals. A random (non-fasting) blood glucose measurement of 140 mg/dL or less is considered normal, while a measurement of 200 mg/dL or more indicates diabetes., Baseline, up to the first 10 days of therapy|Mean Daily Blood Glucose Concentration in Discharged Patients., Blood glucose was measured before each meal and at bedtime, after participants were discharged from the hospital. Mean daily blood glucose concentration was calculated to determine differences in outpatient glycemic control in patients with Type 2 Diabetes (T2D) treated with basal bolus regimen with insulin degludec or glargine once daily plus aspart insulin before meals. Information was collected via bi-weekly phone interviews and during the outpatient study visits at Weeks 4 and 12., Day after hospital discharge to 4 weeks after discharge, 4 to 12 weeks after hospital discharge\n",
      "Sponsor: Emory University\n",
      "Collaborators: Novo Nordisk A/S\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE4\n",
      "Enrollment: 180.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4\n",
      "Brief Summary: Hypoglycemia (low blood glucose level) occurs frequently in intensively treated patients with diabetes. Although hypoglycemia was thought to occur almost exclusively in T1DM, with the advent of improved metabolic control in T2DM, the incidence of hypoglycemia is rising in these patients. Therefore in this application, we will test the novel hypothesis that prior hypoglycemia will result in (cardiovascular complications) during subsequent hypoglycemia.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: OTHER: Hyperinsulinemic Hypoglycemic Clamp\n",
      "Primary Outcome Measure: Percent Changes in Endothelial Function as Measured by Flow Mediated Dilation by 2D Doppler Ultrasound on Day 2, A measure of the baseline arterial dilation on day 2 is compared to the post intervention measure of dilation of the brachial artery on Day 2., baseline on day 2 and ~6 hours later at end of glucose clamp period\n",
      "Sponsor: University of Maryland, Baltimore\n",
      "Collaborators: National Heart, Lung, and Blood Institute (NHLBI)\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: EARLY_PHASE1\n",
      "Enrollment: 20.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers\n",
      "Brief Summary: The primary purpose of this study is to evaluate pharmacodynamics of single oral doses of PF-05175157 in a dose-dependent fashion in healthy volunteers\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: PF-05175157|DRUG: PF-05175157|DRUG: PF-05175157|DRUG: Placebo\n",
      "Primary Outcome Measure: Modulation of carbohydrate and lipid metabolism, 24 hours\n",
      "Sponsor: Pfizer\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 31.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Study of Carrageenan's Effect on Insulin Resistance in Humans\n",
      "Brief Summary: The purpose of this study is to determine whether the ingestion of the common food additive carrageenan contributes to insulin resistance and thus to the pathogenesis of type 2 diabetes in humans.\n",
      "Condition: Diabetes Mellitus, Type 2|Insulin Resistance\n",
      "Intervention: DIETARY_SUPPLEMENT: Carrageenan|DIETARY_SUPPLEMENT: Placebo\n",
      "Primary Outcome Measure: Insulin sensitivity assessed by oral glucose tolerance test (OGTT): Matsuda index, 2 weeks|Insulin sensitivity assessed by hyperinsulinemic clamp: M-value, 2 weeks\n",
      "Sponsor: University Hospital Tuebingen\n",
      "Collaborators: Unknown\n",
      "Sex: MALE\n",
      "Age: ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 20.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Insulin Glargine First Line vs Metformin in Type 2 Diabetic Subjects\n",
      "Brief Summary: Comparison of efficacy and safety of glargine insulin and metformin as first line drug of patients insufficiently treated with lifestyle intervention. So far treatment also algorithm with lifestyle and metformin has not been evaluated in patients with type 2 diabetes and HbA1C greater or equal 7 % and lower than 8.1%.Besides HbA1C postprandial glucose excursion and glycemic variability as determinants of oxidative stress will be measured by continuous glucose measurement(CGM). Further more CGM will reveal risk of hypoglycemia at night. As secondary objectives effect on endothelial function, renal function and biomarkers of low great inflammation will be evaluated. So far only scarce information on face to face comparison in ealy diabetes exists.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DRUG: Metformin|DRUG: Insulin glargine\n",
      "Primary Outcome Measure: Area under the curve (AUC) after a testmeal measured CGM., baseline and visit 8\n",
      "Sponsor: GWT-TUD GmbH\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE4\n",
      "Enrollment: 96.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes\n",
      "Brief Summary: This trial is conducted in China. The aim of the trial is to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of mutiple-dose GZR4 in subjects with type 2 diabetes\n",
      "Condition: Diabetes\n",
      "Intervention: DRUG: GZR4|DRUG: Insulin Degludec\n",
      "Primary Outcome Measure: Incidence of TEAE, Baseline to Week 6\n",
      "Sponsor: Gan and Lee Pharmaceuticals, USA\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 36.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal Impairment\n",
      "Brief Summary: The primary objective of this study is to compare the pharmacokinetics of ASP1941 in type 2 diabetes mellitus patients with normal renal function and those with mild or moderate renal impairment.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: DRUG: ASP1941\n",
      "Primary Outcome Measure: Plasma concentration of ASP1941, For 72 hours after dosing\n",
      "Sponsor: Astellas Pharma Inc\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 25.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy\n",
      "Brief Summary: To compare the glycemic control, as measured by HbA1C, between insulin glargine and rosiglitazone add-on therapies in patients who fail oral combination of a sulfonylurea and metformin\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: DRUG: insulin glargine|DRUG: rosiglitazone|DRUG: metformin\n",
      "Primary Outcome Measure: The primary efficacy variable was the change in HbA1C from baseline to the end of therapy.|Other efficacy variables were the change from baseline in FPG, serum lipids and weight.\n",
      "Sponsor: Sanofi\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE4\n",
      "Enrollment: 220.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Long-term Study of KAD-1229 in Type 2 Diabetes Patients\n",
      "Brief Summary: The purpose of this study is to evaluate the long-term safety and efficacy of KAD-1229 as combination therapy with biguanide or DPP-4 inhibitor in type 2 diabetes patients who show inadequate glycemic control with diet, and biguanide or DPP-4 inhibitor monotherapy.\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DRUG: KAD-1229\n",
      "Primary Outcome Measure: Incidences of Adverse Events, 52 weeks\n",
      "Sponsor: Kissei Pharmaceutical Co., Ltd.\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 136.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes Mellitus\n",
      "Brief Summary: An exploratory study to evaluate the Effect of Improving Glycemic Variability of Anagliptin Compared with Sitagliptin in Patients with Type 2 Diabetes Mellitus\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DRUG: Anagliptin BID Treatment\n",
      "Primary Outcome Measure: Effect of Improving Glycemic Variability, Mean amplitude of glycemic excursion (MAGE), 3 days after 12 weeks treatment\n",
      "Sponsor: JW Pharmaceutical\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE4\n",
      "Enrollment: 89.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes\n",
      "Brief Summary: The trial used a randomized, double-blind, placebo-controlled, superior-effect design, multicenter clinical study.\n",
      "\n",
      "The trial was divided into a test group and a placebo group,the two groups were randomized in a 1:1 ratio and planned to enroll 240 patients with type 2 diabetes. After 2 weeks of screening, all subjects entered the treatment period,which was 24 weeks, and 1 week period of follow-up.\n",
      "Condition: Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: Trelagliptin Succinate|DRUG: Placebo Oral Tablet\n",
      "Primary Outcome Measure: HbA1c, Changes in HbA1c compared to baseline at week 24, Baseline, week 24\n",
      "Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 254.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients\n",
      "Brief Summary: The purpose of this study is to determine whether AZD1656 will affect the Pharmacokinetics and Pharmacodynamics of Warfarin in T2DM patients.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: DRUG: Warfarin|DRUG: Placebo|DRUG: AZD1656\n",
      "Primary Outcome Measure: To evaluate the pharmacokinetics of warfarin after a single dose when administered alone and in combination with AZD1656 at steady state by assessment of AUC and Cmax of both enantiomers of warfarin (S- and R-warfarin)., Serial PK blood samples will be taken on days 4-10 during the treatment periods\n",
      "Sponsor: AstraZeneca\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 16.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers\n",
      "Brief Summary: The objective of this study was to determine the bioequivalence of two different formulations of sitagliptin/ metformin after a single oral dose administration under fed conditions.\n",
      "Condition: Bioequivalence|Type 2 Diabetes\n",
      "Intervention: DRUG: Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet\n",
      "Primary Outcome Measure: Peak Plasma Concentration (Cmax), Evaluation of Peak Plasma Concentration (Cmax), 48 hours|Area under the plasma concentration versus time curve (AUC) 0-t, Evaluation of plasma concentration-time curve from zero to the time of the last measurable time point t, 48 hours\n",
      "Sponsor: Galenicum Health\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE1\n",
      "Enrollment: 26.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: OTHER\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n",
      "Error 404: {\"error\":{\"message\":\"The model `gpt-4-turbo` does not exist or you do not have access to it.\",\"type\":\"invalid_request_error\",\"code\":\"model_not_found\"}}\n",
      "\n",
      "Prompt:\n",
      "Study Title: Coronary Heart Disease Risk in Type 2 Diabetes\n",
      "Brief Summary: The primary objective of the CORDIA study is to use an effective evidence-based self-management intervention (SMI) for type 2 diabetes, with and without a novel test to give a personalised genetic and lifestyle risk of coronary heart disease, to examine their capacity to reduce the risk of coronary heart disease (CHD) and improve diabetes management in primary care patients with type 2 diabetes. The effect of these interventions on clinical, behavioural and psychological outcomes will be investigated.\n",
      "Condition: Coronary Heart Disease|Type 2 Diabetes\n",
      "Intervention: BEHAVIORAL: Self-Management Intervention|BEHAVIORAL: Risk Result\n",
      "Primary Outcome Measure: Coronary heart disease 10 year risk, Coronary heart disease 10 year risk as assessed using the United Kingdon Prospective Diabetes Study (UKPDS) Risk Calculator, 12 months\n",
      "Sponsor: City, University of London\n",
      "Collaborators: University College, London\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 211.0\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\n",
      "\n",
      "Based on the above information, predict if the clinical trial will fail (Completed without results). Answer Yes or No.\n",
      "\n",
      "Response:\n",
      "None\n",
      "--------------------------------------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "# Take a small random sample for testing\n",
    "sample_df = df_selected.sample(100, random_state=42).reset_index(drop=True)\n",
    "\n",
    "predictions = []\n",
    "for prompt in sample_df['prompt']:\n",
    "    reply = query_groq(prompt)\n",
    "    print(f\"Prompt:\\n{prompt}\\n\\nResponse:\\n{reply}\\n{'-'*80}\")\n",
    "    predictions.append(reply)\n",
    "    time.sleep(1)  # Sleep for 1 second between API calls to avoid rate limiting\n",
    "\n",
    "sample_df['llm_response'] = predictions\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "8855320d",
   "metadata": {},
   "outputs": [],
   "source": [
    "def parse_response(response):\n",
    "    if response is None:\n",
    "        return -1\n",
    "    response = response.lower()\n",
    "    if 'yes' in response:\n",
    "        return 1  # Predict Fail\n",
    "    elif 'no' in response:\n",
    "        return 0  # Predict Pass\n",
    "    else:\n",
    "        return -1  # Unable to parse\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "4016f327",
   "metadata": {},
   "outputs": [],
   "source": [
    "sample_df['predicted_label'] = sample_df['llm_response'].apply(parse_response)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "aea9f9c9",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Convert Target column to integers\n",
    "label_mapping = {'PASS': 0, 'FAIL': 1}\n",
    "valid_df['true_label'] = valid_df['Target'].map(label_mapping)\n",
    "\n",
    "# Now, both true_label and predicted_label are integers (0 or 1)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "4ca2956a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Accuracy: 0.2000\n",
      "Precision: 0.0000\n",
      "Recall: 0.0000\n",
      "F1 Score: 0.0000\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "d:\\karan\\interview task\\siro\\.venv\\Lib\\site-packages\\sklearn\\metrics\\_classification.py:1531: UndefinedMetricWarning: Precision is ill-defined and being set to 0.0 due to no predicted samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, f\"{metric.capitalize()} is\", len(result))\n"
     ]
    }
   ],
   "source": [
    "from sklearn.metrics import accuracy_score, precision_score, recall_score, f1_score\n",
    "\n",
    "accuracy = accuracy_score(valid_df['true_label'], valid_df['predicted_label'])\n",
    "precision = precision_score(valid_df['true_label'], valid_df['predicted_label'])\n",
    "recall = recall_score(valid_df['true_label'], valid_df['predicted_label'])\n",
    "f1 = f1_score(valid_df['true_label'], valid_df['predicted_label'])\n",
    "\n",
    "print(f\"Accuracy: {accuracy:.4f}\")\n",
    "print(f\"Precision: {precision:.4f}\")\n",
    "print(f\"Recall: {recall:.4f}\")\n",
    "print(f\"F1 Score: {f1:.4f}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "9ab9f472",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "few_shot_examples = [\n",
    "    {\n",
    "        'Study Title': 'Study of Drug X for Treatment of Diabetes',\n",
    "        'Brief Summary': 'The study investigates Drug X for reducing blood sugar levels...',\n",
    "        'Condition': 'Type 2 Diabetes',\n",
    "        'Intervention': 'DRUG: Drug X',\n",
    "        'Primary Outcome Measure': 'Reduction in HbA1c',\n",
    "        'Sponsor': 'BigPharma Inc.',\n",
    "        'Collaborators': 'University of ABC',\n",
    "        'Sex': 'ALL',\n",
    "        'Age': 'ADULT',\n",
    "        'Phase': 'PHASE3',\n",
    "        'Enrollment': '500',\n",
    "        'Funder Type': 'INDUSTRY',\n",
    "        'Study Type': 'INTERVENTIONAL',\n",
    "        'Study Design': 'Randomized, Double Blind',\n",
    "        'Result': 'PASS'\n",
    "    },\n",
    "    {\n",
    "        'Study Title': 'Study of Compound Y in Patients with Diabetes',\n",
    "        'Brief Summary': 'Compound Y failed to show improvements...',\n",
    "        'Condition': 'Diabetes',\n",
    "        'Intervention': 'DRUG: Compound Y',\n",
    "        'Primary Outcome Measure': 'HbA1c reduction after 6 months',\n",
    "        'Sponsor': 'SmallBioTech Co.',\n",
    "        'Collaborators': 'None',\n",
    "        'Sex': 'ALL',\n",
    "        'Age': 'ADULT',\n",
    "        'Phase': 'PHASE2',\n",
    "        'Enrollment': '50',\n",
    "        'Funder Type': 'OTHER',\n",
    "        'Study Type': 'INTERVENTIONAL',\n",
    "        'Study Design': 'Single-arm, Open Label',\n",
    "        'Result': 'FAIL'\n",
    "    }\n",
    "]\n",
    "\n",
    "def format_example(example):\n",
    "    return (\n",
    "        f\"Study Title: {example['Study Title']}\\n\"\n",
    "        f\"Brief Summary: {example['Brief Summary']}\\n\"\n",
    "        f\"Condition: {example['Condition']}\\n\"\n",
    "        f\"Intervention: {example['Intervention']}\\n\"\n",
    "        f\"Primary Outcome Measure: {example['Primary Outcome Measure']}\\n\"\n",
    "        f\"Sponsor: {example['Sponsor']}\\n\"\n",
    "        f\"Collaborators: {example['Collaborators']}\\n\"\n",
    "        f\"Sex: {example['Sex']}\\n\"\n",
    "        f\"Age: {example['Age']}\\n\"\n",
    "        f\"Phase: {example['Phase']}\\n\"\n",
    "        f\"Enrollment: {example['Enrollment']}\\n\"\n",
    "        f\"Funder Type: {example['Funder Type']}\\n\"\n",
    "        f\"Study Type: {example['Study Type']}\\n\"\n",
    "        f\"Study Design: {example['Study Design']}\\n\"\n",
    "        f\"Result: {example['Result']}\\n\"\n",
    "    )\n",
    "\n",
    "few_shot_prompt = \"\"\n",
    "for ex in few_shot_examples:\n",
    "    few_shot_prompt += format_example(ex) + \"\\n\"\n",
    "\n",
    "def create_few_shot_prompt(row):\n",
    "    new_trial = (\n",
    "        f\"Study Title: {row['Study Title']}\\n\"\n",
    "        f\"Brief Summary: {row['Brief Summary']}\\n\"\n",
    "        f\"Condition: {row['Conditions']}\\n\"\n",
    "        f\"Intervention: {row['Interventions']}\\n\"\n",
    "        f\"Primary Outcome Measure: {row['Primary Outcome Measures']}\\n\"\n",
    "        f\"Sponsor: {row['Sponsor']}\\n\"\n",
    "        f\"Collaborators: {row['Collaborators']}\\n\"\n",
    "        f\"Sex: {row['Sex']}\\n\"\n",
    "        f\"Age: {row['Age']}\\n\"\n",
    "        f\"Phase: {row['Phases']}\\n\"\n",
    "        f\"Enrollment: {row['Enrollment']}\\n\"\n",
    "        f\"Funder Type: {row['Funder Type']}\\n\"\n",
    "        f\"Study Type: {row['Study Type']}\\n\"\n",
    "        f\"Study Design: {row['Study Design']}\\n\"\n",
    "        \"\\nPredict the Result (Answer exactly FAIL or PASS):\"\n",
    "    )\n",
    "    return few_shot_prompt + \"\\n\" + new_trial\n",
    "\n",
    "# Apply\n",
    "df_selected['few_shot_prompt'] = df_selected.apply(create_few_shot_prompt, axis=1)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "50755c68",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "\n",
    "def query_groq(prompt):\n",
    "    url = \"https://api.groq.com/openai/v1/chat/completions\"\n",
    "    headers = {\n",
    "        \"Authorization\": f\"Bearer {GROQ_API_KEY}\",\n",
    "        \"Content-Type\": \"application/json\"\n",
    "    }\n",
    "    data = {\n",
    "        \"model\": \"llama3-8b-8192\",  # Still using llama3-8b\n",
    "        \"messages\": [{\"role\": \"user\", \"content\": prompt}],\n",
    "        \"temperature\": 0.2,  # Low temperature = less randomness\n",
    "        \"max_tokens\": 50      # Allow bigger output so it can explain\n",
    "    }\n",
    "    try:\n",
    "        response = requests.post(url, headers=headers, json=data)\n",
    "        if response.status_code == 200:\n",
    "            result = response.json()\n",
    "            reply = result['choices'][0]['message']['content']\n",
    "            return reply.strip()\n",
    "        else:\n",
    "            print(f\"Error {response.status_code}: {response.text}\")\n",
    "            return None\n",
    "    except Exception as e:\n",
    "        print(f\"Request failed: {e}\")\n",
    "        return None\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "49be98a9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Prompt:\n",
      "Study Title: Study of Drug X for Treatment of Diabetes\n",
      "Brief Summary: The study investigates Drug X for reducing blood sugar levels...\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DRUG: Drug X\n",
      "Primary Outcome Measure: Reduction in HbA1c\n",
      "Sponsor: BigPharma Inc.\n",
      "Collaborators: University of ABC\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 500\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Randomized, Double Blind\n",
      "Result: PASS\n",
      "\n",
      "Study Title: Study of Compound Y in Patients with Diabetes\n",
      "Brief Summary: Compound Y failed to show improvements...\n",
      "Condition: Diabetes\n",
      "Intervention: DRUG: Compound Y\n",
      "Primary Outcome Measure: HbA1c reduction after 6 months\n",
      "Sponsor: SmallBioTech Co.\n",
      "Collaborators: None\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: PHASE2\n",
      "Enrollment: 50\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Single-arm, Open Label\n",
      "Result: FAIL\n",
      "\n",
      "\n",
      "Study Title: Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus\n",
      "Brief Summary: This trial is conducted globally. The aim of this trial is to investigate efficacy and safety of oral Semaglutide versus Liraglutide and versus Placebo in Subjects with Type 2 Diabetes Mellitus.\n",
      "Condition: Diabetes|Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: semaglutide|DRUG: liraglutide|DRUG: placebo\n",
      "Primary Outcome Measure: Change in HbA1c (Week 26), Change from baseline (week 0) in glycosylated haemoglobin (HbA1c) was evaluated at week 26. The endpoint was evaluated based on the data from the in-trial observation period, which was the time period from when a participant was randomised until the final scheduled visit, including any period after initiation of rescue medication and/or premature discontinuation of trial product. The endpoint was also evaluated based on the data from the on-treatment without rescue medication observation period, which was the time period when a participant was on treatment with trial product, excluding any period after initiation of rescue medication and/or premature trial product discontinuation., Week 0, week 26\n",
      "Sponsor: Novo Nordisk A/S\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 711.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Predict the Result (Answer exactly FAIL or PASS):\n",
      "\n",
      "Response:\n",
      "Based on the study design and summary, I predict the result to be:\n",
      "\n",
      "PASS\n",
      "--------------------------------------------------------------------------------\n",
      "Prompt:\n",
      "Study Title: Study of Drug X for Treatment of Diabetes\n",
      "Brief Summary: The study investigates Drug X for reducing blood sugar levels...\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DRUG: Drug X\n",
      "Primary Outcome Measure: Reduction in HbA1c\n",
      "Sponsor: BigPharma Inc.\n",
      "Collaborators: University of ABC\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 500\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Randomized, Double Blind\n",
      "Result: PASS\n",
      "\n",
      "Study Title: Study of Compound Y in Patients with Diabetes\n",
      "Brief Summary: Compound Y failed to show improvements...\n",
      "Condition: Diabetes\n",
      "Intervention: DRUG: Compound Y\n",
      "Primary Outcome Measure: HbA1c reduction after 6 months\n",
      "Sponsor: SmallBioTech Co.\n",
      "Collaborators: None\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: PHASE2\n",
      "Enrollment: 50\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Single-arm, Open Label\n",
      "Result: FAIL\n",
      "\n",
      "\n",
      "Study Title: Evaluate the Safety and Efficacy of Sinocare CGM System Regarding Real Time Glucose Level Monitoring\n",
      "Brief Summary: From Jan 2022 to June 2022, 120 subjects (22-75 years of age, mean ±standard deviation \\[SD\\] of 53.20 ±14.49 years) with type 1 or type 2 diabetes participated in the study in P.R. China. Subjects wore two sensors in the abdomen which were paired with smart devices running a glucose monitoring mobile application (i3/H3 CGM APP). Subjects were asked to undergo one in-clinic visit (on one of the study days 2, 7-9, or 15) for 7-hour long YSI frequent sampling test (FST) periods, where intravenous (IV) blood samples were drawn every 15 min and analyzed using the YSI 2300 STAT Plus Glucose \\& Lactate Analyzer (Yellow Springs Instrument, YSI Life Sciences, Yellow Springs, OH).\n",
      "Condition: Type 1 or Type 2 Diabetes\n",
      "Intervention: Unknown\n",
      "Primary Outcome Measure: overall mean absolute relative difference (MARD), 8 or 15 days\n",
      "Sponsor: Sinocare\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 120.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Predict the Result (Answer exactly FAIL or PASS):\n",
      "\n",
      "Response:\n",
      "Based on the study design and brief summary, I predict the result as:\n",
      "\n",
      "FAIL\n",
      "--------------------------------------------------------------------------------\n",
      "Prompt:\n",
      "Study Title: Study of Drug X for Treatment of Diabetes\n",
      "Brief Summary: The study investigates Drug X for reducing blood sugar levels...\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DRUG: Drug X\n",
      "Primary Outcome Measure: Reduction in HbA1c\n",
      "Sponsor: BigPharma Inc.\n",
      "Collaborators: University of ABC\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 500\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Randomized, Double Blind\n",
      "Result: PASS\n",
      "\n",
      "Study Title: Study of Compound Y in Patients with Diabetes\n",
      "Brief Summary: Compound Y failed to show improvements...\n",
      "Condition: Diabetes\n",
      "Intervention: DRUG: Compound Y\n",
      "Primary Outcome Measure: HbA1c reduction after 6 months\n",
      "Sponsor: SmallBioTech Co.\n",
      "Collaborators: None\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: PHASE2\n",
      "Enrollment: 50\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Single-arm, Open Label\n",
      "Result: FAIL\n",
      "\n",
      "\n",
      "Study Title: Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.\n",
      "Brief Summary: Fluid management study in patients with type 2 diabetes and autonomic neuropathy.\n",
      "Condition: Neuropathy, Diabetic\n",
      "Intervention: DRUG: rosiglitazone\n",
      "Primary Outcome Measure: Change in transcapillary escape rate of L125 albumin following 16 weeks treatment\n",
      "Sponsor: GlaxoSmithKline\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 36.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Predict the Result (Answer exactly FAIL or PASS):\n",
      "\n",
      "Response:\n",
      "Based on the study design and characteristics, I predict the result of the third study to be:\n",
      "\n",
      "PASS\n",
      "--------------------------------------------------------------------------------\n",
      "Prompt:\n",
      "Study Title: Study of Drug X for Treatment of Diabetes\n",
      "Brief Summary: The study investigates Drug X for reducing blood sugar levels...\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DRUG: Drug X\n",
      "Primary Outcome Measure: Reduction in HbA1c\n",
      "Sponsor: BigPharma Inc.\n",
      "Collaborators: University of ABC\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 500\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Randomized, Double Blind\n",
      "Result: PASS\n",
      "\n",
      "Study Title: Study of Compound Y in Patients with Diabetes\n",
      "Brief Summary: Compound Y failed to show improvements...\n",
      "Condition: Diabetes\n",
      "Intervention: DRUG: Compound Y\n",
      "Primary Outcome Measure: HbA1c reduction after 6 months\n",
      "Sponsor: SmallBioTech Co.\n",
      "Collaborators: None\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: PHASE2\n",
      "Enrollment: 50\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Single-arm, Open Label\n",
      "Result: FAIL\n",
      "\n",
      "\n",
      "Study Title: Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections\n",
      "Brief Summary: Liraglutide, a GLP-1-analogue has been shown to be an effective treatment option in patients on oral anti-diabetes therapy with beneficial effects on both glycaemic control and weight. However, to date there are no clinical trials of liraglutide added to insulin therapy, a population of patients generally having worse glycaemic control and weight gain. In clinical guidelines, use of multiple daily insulin injections (MDI) is usually the final therapeutic option for type 2 diabetic patients.\n",
      "\n",
      "The primary study aim is to evaluate whether the addition of liraglutide, compared to placebo, reduces the HbA1c level for overweight and obese type 2 diabetes patients with inadequate glycaemic control treated with multiple daily insulin injections (MDI). MDI is defined as treatment with any basal insulin combined with separate meal time insulin injections before the main meals, i.e. an insulin regimen with premixed insulin is not considered as MDI.\n",
      "\n",
      "The planned study duration is 24 weeks and includes 120 patients at 15 centers in Sweden.\n",
      "Condition: Type 2 Diabetes Mellitus\n",
      "Intervention: DRUG: Liraglutide|DRUG: Placebo\n",
      "Primary Outcome Measure: Change in HbA1c from baseline to week 24., Baseline, week 24\n",
      "Sponsor: Vastra Gotaland Region\n",
      "Collaborators: Novo Nordisk A/S\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: PHASE2\n",
      "Enrollment: 124.0\n",
      "Funder Type: OTHER_GOV\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\n",
      "\n",
      "Predict the Result (Answer exactly FAIL or PASS):\n",
      "\n",
      "Response:\n",
      "Based on the study design and summary, I predict the result to be:\n",
      "\n",
      "PASS\n",
      "--------------------------------------------------------------------------------\n",
      "Prompt:\n",
      "Study Title: Study of Drug X for Treatment of Diabetes\n",
      "Brief Summary: The study investigates Drug X for reducing blood sugar levels...\n",
      "Condition: Type 2 Diabetes\n",
      "Intervention: DRUG: Drug X\n",
      "Primary Outcome Measure: Reduction in HbA1c\n",
      "Sponsor: BigPharma Inc.\n",
      "Collaborators: University of ABC\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: PHASE3\n",
      "Enrollment: 500\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Randomized, Double Blind\n",
      "Result: PASS\n",
      "\n",
      "Study Title: Study of Compound Y in Patients with Diabetes\n",
      "Brief Summary: Compound Y failed to show improvements...\n",
      "Condition: Diabetes\n",
      "Intervention: DRUG: Compound Y\n",
      "Primary Outcome Measure: HbA1c reduction after 6 months\n",
      "Sponsor: SmallBioTech Co.\n",
      "Collaborators: None\n",
      "Sex: ALL\n",
      "Age: ADULT\n",
      "Phase: PHASE2\n",
      "Enrollment: 50\n",
      "Funder Type: OTHER\n",
      "Study Type: INTERVENTIONAL\n",
      "Study Design: Single-arm, Open Label\n",
      "Result: FAIL\n",
      "\n",
      "\n",
      "Study Title: Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes\n",
      "Brief Summary: This study is conducted in Africa. The aim of this study is to assess the safety and efficacy of Levemir® treatment for insulin naive patients with type 2 diabetes under normal clinical practice conditions in Algeria.\n",
      "Condition: Diabetes|Diabetes Mellitus, Type 2\n",
      "Intervention: DRUG: insulin detemir\n",
      "Primary Outcome Measure: Assessment the incidence of the Serious Adverse Events including the major Hypoglycaemia., During study\n",
      "Sponsor: Novo Nordisk A/S\n",
      "Collaborators: Unknown\n",
      "Sex: ALL\n",
      "Age: ADULT, OLDER_ADULT\n",
      "Phase: Unknown\n",
      "Enrollment: 1976.0\n",
      "Funder Type: INDUSTRY\n",
      "Study Type: OBSERVATIONAL\n",
      "Study Design: Observational Model: |Time Perspective: p\n",
      "\n",
      "Predict the Result (Answer exactly FAIL or PASS):\n",
      "\n",
      "Response:\n",
      "Based on the information provided, I predict the result of the Observational Study to be:\n",
      "\n",
      "PASS\n",
      "\n",
      "The study is observational, and the primary outcome measure is assessing the incidence of serious adverse events, including major hypoglycaemia, during the study\n",
      "--------------------------------------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "# Small sample batch to test\n",
    "sample_df = df_selected.sample(5, random_state=42).reset_index(drop=True)\n",
    "\n",
    "predictions = []\n",
    "for prompt in sample_df['few_shot_prompt']:\n",
    "    reply = query_groq(prompt)\n",
    "    print(f\"Prompt:\\n{prompt}\\n\\nResponse:\\n{reply}\\n{'-'*80}\")\n",
    "    predictions.append(reply)\n",
    "    time.sleep(1)  # Be polite to GROQ API\n",
    "\n",
    "sample_df['llm_response'] = predictions\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "c35852fa",
   "metadata": {},
   "outputs": [],
   "source": [
    "def parse_response(response):\n",
    "    if response is None:\n",
    "        return -1\n",
    "    response = response.lower()\n",
    "    if 'fail' in response:\n",
    "        return 1  # Trial predicted to fail\n",
    "    elif 'pass' in response:\n",
    "        return 0  # Trial predicted to pass\n",
    "    else:\n",
    "        return -1  # Could not parse\n",
    "\n",
    "sample_df['predicted_label'] = sample_df['llm_response'].apply(parse_response)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "3a18e21b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Accuracy: 0.4000\n",
      "Precision: 1.0000\n",
      "Recall: 0.2500\n",
      "F1 Score: 0.4000\n"
     ]
    }
   ],
   "source": [
    "    # Convert true labels from text to 0/1\n",
    "label_mapping = {'PASS': 0, 'FAIL': 1}\n",
    "sample_df['true_label'] = sample_df['Target'].map(label_mapping)\n",
    "\n",
    "# Filter valid rows\n",
    "valid_df = sample_df[sample_df['predicted_label'] != -1]\n",
    "\n",
    "from sklearn.metrics import accuracy_score, precision_score, recall_score, f1_score\n",
    "\n",
    "accuracy = accuracy_score(valid_df['true_label'], valid_df['predicted_label'])\n",
    "precision = precision_score(valid_df['true_label'], valid_df['predicted_label'])\n",
    "recall = recall_score(valid_df['true_label'], valid_df['predicted_label'])\n",
    "f1 = f1_score(valid_df['true_label'], valid_df['predicted_label'])\n",
    "\n",
    "print(f\"Accuracy: {accuracy:.4f}\")\n",
    "print(f\"Precision: {precision:.4f}\")\n",
    "print(f\"Recall: {recall:.4f}\")\n",
    "print(f\"F1 Score: {f1:.4f}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "6ab65362",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Sample 200 rows randomly\n",
    "big_sample_df = df_selected.sample(200, random_state=42).reset_index(drop=True)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "c1db666d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1: Based on the study design and primary outcome measure, I predict the result to be:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "2: Based on the study design and brief summary, I predict the result as:\n",
      "\n",
      "FAIL\n",
      "------------------------------------------------------------\n",
      "3: Based on the study design and characteristics, I predict the result of the third study to be:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "4: Based on the study design and primary outcome measure, I predict the result to be:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "5: Based on the information provided, I predict the result of the third study as:\n",
      "\n",
      "PASS\n",
      "\n",
      "The study is an observational study, which means it is not an interventional study, and the primary outcome measure is assessing the incidence of serious adverse events, including\n",
      "------------------------------------------------------------\n",
      "6: Based on the study design and description, I predict the result as:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is observational, not interventional, and the primary outcome measures are not focused on a specific treatment effect. The study aims to generate real-world data on drug utilization\n",
      "------------------------------------------------------------\n",
      "7: Based on the study design and brief summary, I predict the result of the DASH4D trial as:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "8: Based on the study design and results, I predict the result to be:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "9: Based on the study design and brief summary, I predict the result of the third study to be:\n",
      "\n",
      "FAIL\n",
      "------------------------------------------------------------\n",
      "10: Based on the brief summaries and study designs, I predict the result of the third study as:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is investigating the effect of Moringa oleifera leaves on glycemic control in women with type 2 diabetes, and the primary\n",
      "------------------------------------------------------------\n",
      "11: Based on the study design and brief summary, I predict the result of the third study as:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is a quasi-experimental study with a single-group design, which means it lacks a control group and randomization. Additionally, the study\n",
      "------------------------------------------------------------\n",
      "12: Based on the information provided, I predict the result of the third study to be:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The reason is that the study is observational, not interventional, and the primary outcome measures are genetic markers, not a treatment outcome. The study is evaluating\n",
      "------------------------------------------------------------\n",
      "13: Based on the study design and brief summary, I predict the result of the Onduo Virtual Diabetes Clinic Study to be:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5806, Requested 426. Please try again in 2.312s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "14: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5697, Requested 501. Please try again in 1.978s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "15: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5586, Requested 490. Please try again in 753.999999ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "16: None\n",
      "------------------------------------------------------------\n",
      "17: Based on the study design and characteristics, I predict the result as:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5816, Requested 471. Please try again in 2.864s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "18: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5707, Requested 579. Please try again in 2.851s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "19: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5599, Requested 668. Please try again in 2.663999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "20: None\n",
      "------------------------------------------------------------\n",
      "21: Based on the study design and characteristics, I predict the result of the third study as:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is observational, does not involve an intervention, and is focused on investigating the association between thyroid function and diabetes complications. The primary outcome measure is\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5811, Requested 398. Please try again in 2.089s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "22: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5702, Requested 820. Please try again in 5.217s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "23: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5594, Requested 424. Please try again in 171.999999ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "24: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5482, Requested 609. Please try again in 910ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "25: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5371, Requested 674. Please try again in 448.999999ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "26: None\n",
      "------------------------------------------------------------\n",
      "27: Based on the study design and outcome measures, I predict the result of the third study to be:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5657, Requested 424. Please try again in 808ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "28: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5547, Requested 1526. Please try again in 10.729s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "29: None\n",
      "------------------------------------------------------------\n",
      "30: Based on the study design and characteristics, I predict the result for the third study as:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is investigating the mechanisms by which strength training ameliorates the Metabolic Syndrome, and it's a behavioral intervention (strength training) with a\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5828, Requested 568. Please try again in 3.956s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "31: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5718, Requested 488. Please try again in 2.052s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "32: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5609, Requested 549. Please try again in 1.573s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "33: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5500, Requested 723. Please try again in 2.226s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "34: None\n",
      "------------------------------------------------------------\n",
      "35: Based on the study design and characteristics, I predict the result for the third study as:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is observational, not interventional, and aims to improve tools for measuring insulin function, rather than testing a specific treatment. The primary outcome measure\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5801, Requested 485. Please try again in 2.857s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "36: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5689, Requested 520. Please try again in 2.086999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "37: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5574, Requested 4566. Please try again in 41.394s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "38: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5465, Requested 740. Please try again in 2.047s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "39: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5353, Requested 1033. Please try again in 3.852999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "40: None\n",
      "------------------------------------------------------------\n",
      "41: Based on the study design and brief summary, I predict the result for each study as follows:\n",
      "\n",
      "1. Study of Drug X for Treatment of Diabetes: **PASS**\n",
      "The study is a randomized, double-blind, Phase 3 trial with a primary outcome\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5609, Requested 770. Please try again in 3.783s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "42: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5499, Requested 593. Please try again in 920ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "43: None\n",
      "------------------------------------------------------------\n",
      "44: Based on the study designs and results, I predict the results as follows:\n",
      "\n",
      "1. Study of Drug X for Treatment of Diabetes: PASS\n",
      "2. Study of Compound Y in Patients with Diabetes: FAIL\n",
      "3. A Randomized Trial to Slow the\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5834, Requested 677. Please try again in 5.107s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "45: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5718, Requested 2195. Please try again in 19.124s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "46: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5609, Requested 433. Please try again in 411ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "47: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5500, Requested 524. Please try again in 231ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "48: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5389, Requested 703. Please try again in 913.999999ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "49: None\n",
      "------------------------------------------------------------\n",
      "50: Based on the study design and brief summary, I predict the result to be:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5752, Requested 584. Please try again in 3.353999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "51: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5642, Requested 500. Please try again in 1.412s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "52: None\n",
      "------------------------------------------------------------\n",
      "53: Based on the study design and characteristics, I predict the result of the third study as:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5877, Requested 761. Please try again in 6.372s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "54: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5768, Requested 433. Please try again in 2.001s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "55: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5658, Requested 1015. Please try again in 6.725s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "56: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5549, Requested 596. Please try again in 1.445s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "57: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5436, Requested 5157. Please try again in 45.922s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "58: None\n",
      "------------------------------------------------------------\n",
      "59: Based on the information provided, I predict the result of the third study as:\n",
      "\n",
      "FAIL\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5643, Requested 524. Please try again in 1.67s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "60: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5534, Requested 740. Please try again in 2.733s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "61: None\n",
      "------------------------------------------------------------\n",
      "62: Based on the study design and description, I predict the result of the third study as:\n",
      "\n",
      "FAIL\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5791, Requested 452. Please try again in 2.426s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "63: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5679, Requested 1057. Please try again in 7.36s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "64: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5569, Requested 475. Please try again in 436ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "65: None\n",
      "------------------------------------------------------------\n",
      "66: Based on the study design and characteristics, I predict the result of the third study as:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is investigating the impact of ischemic preconditioning on vascular function and insulin sensitivity in Type 2 Diabetes Mellitus, and it's a small\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5842, Requested 451. Please try again in 2.929s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "67: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5731, Requested 466. Please try again in 1.961s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "68: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5620, Requested 637. Please try again in 2.562s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "69: None\n",
      "------------------------------------------------------------\n",
      "70: Based on the study design and characteristics, I predict the result for the third study as:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5911, Requested 447. Please try again in 3.58s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "71: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5803, Requested 487. Please try again in 2.897s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "72: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5691, Requested 715. Please try again in 4.059s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "73: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5580, Requested 670. Please try again in 2.491s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "74: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5470, Requested 693. Please try again in 1.626s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "75: None\n",
      "------------------------------------------------------------\n",
      "76: Based on the study design and phase, I predict the result of the Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients as:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5694, Requested 560. Please try again in 2.54s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "77: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5582, Requested 423. Please try again in 48ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "78: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5467, Requested 880. Please try again in 3.464s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "79: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5358, Requested 1080. Please try again in 4.376s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "80: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5247, Requested 1243. Please try again in 4.894s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "81: None\n",
      "------------------------------------------------------------\n",
      "82: Based on the study design and primary outcome measure, I predict the result for each study as follows:\n",
      "\n",
      "1. Study of Drug X for Treatment of Diabetes: PASS\n",
      "\t* The study is a randomized, double-blind, Phase 3 trial with a\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5532, Requested 528. Please try again in 595ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "83: None\n",
      "------------------------------------------------------------\n",
      "84: Based on the study design and description, I predict the result to be:\n",
      "\n",
      "FAIL\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5885, Requested 626. Please try again in 5.101s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "85: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5776, Requested 782. Please try again in 5.575s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "86: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5664, Requested 758. Please try again in 4.215s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "87: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5555, Requested 561. Please try again in 1.156s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "88: None\n",
      "------------------------------------------------------------\n",
      "89: Based on the study design and phase, I predict the result for the third study as:\n",
      "\n",
      "FAIL\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5766, Requested 458. Please try again in 2.237s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "90: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5649, Requested 557. Please try again in 2.053s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "91: None\n",
      "------------------------------------------------------------\n",
      "92: Based on the information provided, I predict the result of the third study as:\n",
      "\n",
      "FAIL\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5875, Requested 423. Please try again in 2.971s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "93: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5766, Requested 458. Please try again in 2.234s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "94: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5656, Requested 422. Please try again in 780ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "95: None\n",
      "------------------------------------------------------------\n",
      "96: Based on the study design and characteristics, I predict the result of the third study as:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5874, Requested 504. Please try again in 3.776999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "97: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5762, Requested 479. Please try again in 2.409s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "98: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5654, Requested 488. Please try again in 1.411s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "99: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5545, Requested 533. Please try again in 771.999999ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "100: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5434, Requested 597. Please try again in 306ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "101: None\n",
      "------------------------------------------------------------\n",
      "102: Based on the study design and information provided, I predict the result of the third study to be:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5706, Requested 427. Please try again in 1.325s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "103: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5597, Requested 420. Please try again in 165ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "104: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5488, Requested 1260. Please try again in 7.471s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "105: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5376, Requested 727. Please try again in 1.027999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "106: None\n",
      "------------------------------------------------------------\n",
      "107: Based on the study design and information provided, I predict the result of the third study to be:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5601, Requested 682. Please try again in 2.83s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "108: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5492, Requested 513. Please try again in 46ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "109: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5383, Requested 822. Please try again in 2.047999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "110: None\n",
      "------------------------------------------------------------\n",
      "111: Based on the study design and brief summary, I predict the result for each study as follows:\n",
      "\n",
      "1. Study of Drug X for Treatment of Diabetes: PASS\n",
      "The study is a randomized, double-blind, Phase 3 trial with a large sample size\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5671, Requested 466. Please try again in 1.368999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "112: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5563, Requested 786. Please try again in 3.487s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "113: None\n",
      "------------------------------------------------------------\n",
      "114: Based on the study design and characteristics, I predict the result of the third study as:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5828, Requested 600. Please try again in 4.272s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "115: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5718, Requested 1067. Please try again in 7.846s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "116: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5605, Requested 556. Please try again in 1.601999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "117: None\n",
      "------------------------------------------------------------\n",
      "118: Based on the study design and type, I predict the result as:\n",
      "\n",
      "FAIL\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5870, Requested 460. Please try again in 3.299s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "119: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5762, Requested 474. Please try again in 2.358s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "120: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5652, Requested 475. Please try again in 1.265s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "121: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5542, Requested 707. Please try again in 2.487s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "122: None\n",
      "------------------------------------------------------------\n",
      "123: Based on the study design and brief summary, I predict the result of GLiMPSE as:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is a phase 1, non-randomized, single-arm study, which is typically used to evaluate the feasibility and acceptability of\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5809, Requested 443. Please try again in 2.519s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "124: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5701, Requested 503. Please try again in 2.037s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "125: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5588, Requested 557. Please try again in 1.446s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "126: None\n",
      "------------------------------------------------------------\n",
      "127: Based on the study design and characteristics, I predict the result for each study as follows:\n",
      "\n",
      "1. Study of Drug X for Treatment of Diabetes: PASS\n",
      "\t* The study is a Phase 3, randomized, double-blind trial with 500 participants\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5922, Requested 739. Please try again in 6.608s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "128: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5815, Requested 677. Please try again in 4.911s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "129: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5705, Requested 773. Please try again in 4.777s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "130: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5594, Requested 520. Please try again in 1.138s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "131: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5485, Requested 600. Please try again in 843.999999ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "132: None\n",
      "------------------------------------------------------------\n",
      "133: Based on the study design and description, I predict the result to be:\n",
      "\n",
      "FAIL\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5785, Requested 628. Please try again in 4.123s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "134: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5675, Requested 527. Please try again in 2.013s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "135: None\n",
      "------------------------------------------------------------\n",
      "136: Based on the study design and characteristics, I predict the result for the third study as:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5863, Requested 528. Please try again in 3.904s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "137: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5741, Requested 637. Please try again in 3.773999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "138: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5633, Requested 444. Please try again in 763ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "139: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5524, Requested 586. Please try again in 1.091999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "140: None\n",
      "------------------------------------------------------------\n",
      "141: Based on the study design and primary outcome measure, I predict the result to be:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5845, Requested 425. Please try again in 2.697s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "142: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5735, Requested 455. Please try again in 1.898s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "143: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5623, Requested 606. Please try again in 2.29s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "144: None\n",
      "------------------------------------------------------------\n",
      "145: Based on the study design and characteristics, I predict the result for the third study as:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is a non-interventional, post-marketing surveillance (PMS) study, which means it is an observational study that aims to evaluate\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5905, Requested 594. Please try again in 4.984s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "146: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5794, Requested 691. Please try again in 4.842s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "147: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5679, Requested 457. Please try again in 1.36s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "148: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5571, Requested 468. Please try again in 386ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "149: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5461, Requested 556. Please try again in 163.999999ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "150: None\n",
      "------------------------------------------------------------\n",
      "151: Based on the study design and outcome measures, I predict the result for each study as follows:\n",
      "\n",
      "1. Study of Drug X for Treatment of Diabetes: PASS\n",
      "\t* The study is a Phase 3 randomized, double-blind trial with a primary outcome\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5762, Requested 439. Please try again in 2.001s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "152: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5652, Requested 466. Please try again in 1.171s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "153: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5543, Requested 494. Please try again in 365ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "154: None\n",
      "------------------------------------------------------------\n",
      "155: Based on the brief summaries and study designs, I predict the result of the third study as:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is observational, not interventional, and aims to evaluate the impact of insulin resistance on the incretin effect in lean and obese patients with\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5852, Requested 1020. Please try again in 8.718s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "156: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5744, Requested 607. Please try again in 3.51s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "157: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5635, Requested 545. Please try again in 1.796s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "158: None\n",
      "------------------------------------------------------------\n",
      "159: Based on the study design and characteristics, I predict the result of the Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes as:\n",
      "\n",
      "FAIL\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5861, Requested 425. Please try again in 2.856s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "160: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5751, Requested 489. Please try again in 2.393s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "161: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5642, Requested 602. Please try again in 2.435s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "162: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5532, Requested 726. Please try again in 2.575s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "163: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5420, Requested 830. Please try again in 2.494s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "164: None\n",
      "------------------------------------------------------------\n",
      "165: Based on the study design and characteristics, I predict the result of the third study as:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5694, Requested 474. Please try again in 1.672s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "166: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5585, Requested 1105. Please try again in 6.894s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "167: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5476, Requested 876. Please try again in 3.511s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "168: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5364, Requested 1040. Please try again in 4.034s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "169: None\n",
      "------------------------------------------------------------\n",
      "170: Based on the study design and type, I predict the result as:\n",
      "\n",
      "FAIL\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5540, Requested 761. Please try again in 3.002s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "171: None\n",
      "------------------------------------------------------------\n",
      "172: Based on the study design and characteristics, I predict the result of the third study to be:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5812, Requested 412. Please try again in 2.237s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "173: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5700, Requested 512. Please try again in 2.112s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "174: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5589, Requested 716. Please try again in 3.05s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "175: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5480, Requested 728. Please try again in 2.072999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "176: None\n",
      "------------------------------------------------------------\n",
      "177: Based on the study design and brief summary, I predict the result to be:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is evaluating the efficacy and safety of a new ubiquitous healthcare service using voice inception technique, which is expected to improve glycemic control without specific devices. The\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5793, Requested 611. Please try again in 4.038999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "178: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5679, Requested 426. Please try again in 1.046999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "179: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5570, Requested 434. Please try again in 35ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "180: None\n",
      "------------------------------------------------------------\n",
      "181: Based on the study design and brief summary, I predict the result to be:\n",
      "\n",
      "FAIL\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5865, Requested 443. Please try again in 3.078999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "182: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5757, Requested 515. Please try again in 2.711999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "183: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5644, Requested 515. Please try again in 1.581s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "184: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5534, Requested 624. Please try again in 1.578s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "185: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5424, Requested 662. Please try again in 858.999999ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "186: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5315, Requested 937. Please try again in 2.516s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "187: None\n",
      "------------------------------------------------------------\n",
      "188: Based on the study design and characteristics, I predict the result for the third study as:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is a single-arm, open-label study, which is typically less rigorous than a randomized, double-blind study. Additionally, the study is not\n",
      "------------------------------------------------------------\n",
      "189: Based on the study design and summary, I predict the result to be:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is a basic science study examining the effects of pioglitazone on insulin sensitivity and adipokines, and does not appear to be a clinical trial\n",
      "------------------------------------------------------------\n",
      "190: Based on the study design and characteristics, I predict the result of the third study as:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5710, Requested 508. Please try again in 2.171s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "191: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5600, Requested 550. Please try again in 1.491s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "192: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5478, Requested 759. Please try again in 2.367999999s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "193: None\n",
      "------------------------------------------------------------\n",
      "194: Based on the study design and characteristics, I predict the result of the GUARD Study to be:\n",
      "\n",
      "PASS\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5761, Requested 971. Please try again in 7.317s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "195: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5649, Requested 924. Please try again in 5.729s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "196: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5538, Requested 536. Please try again in 736ms. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "197: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5430, Requested 1341. Please try again in 7.706s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "198: None\n",
      "------------------------------------------------------------\n",
      "Error 429: {\"error\":{\"message\":\"Rate limit reached for model `llama3-8b-8192` in organization `org_01jwmxn44ke3s96pzq3175adp5` service tier `on_demand` on tokens per minute (TPM): Limit 6000, Used 5320, Requested 1008. Please try again in 3.276s. Need more tokens? Upgrade to Dev Tier today at https://console.groq.com/settings/billing\",\"type\":\"tokens\",\"code\":\"rate_limit_exceeded\"}}\n",
      "\n",
      "199: None\n",
      "------------------------------------------------------------\n",
      "200: Based on the study design and characteristics, I predict the result of the third study as:\n",
      "\n",
      "FAIL\n",
      "\n",
      "The study is a behavioral intervention study, aiming to evaluate the effects of lifestyle modifications on insulin sensitivity and adipokines in type 2 diabetic women.\n",
      "------------------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "import time\n",
    "\n",
    "predictions = []\n",
    "\n",
    "for i, prompt in enumerate(big_sample_df['few_shot_prompt']):\n",
    "    reply = query_groq(prompt)\n",
    "    print(f\"{i+1}: {reply}\\n{'-'*60}\")\n",
    "    predictions.append(reply)\n",
    "    time.sleep(1)  # Sleep for 1 second between calls\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "3a7db14d",
   "metadata": {},
   "outputs": [],
   "source": [
    "big_sample_df['llm_response'] = predictions\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "e8079337",
   "metadata": {},
   "outputs": [],
   "source": [
    "def parse_response(response):\n",
    "    if response is None:\n",
    "        return -1\n",
    "    response = response.lower()\n",
    "    if 'fail' in response:\n",
    "        return 1\n",
    "    elif 'pass' in response:\n",
    "        return 0\n",
    "    else:\n",
    "        return -1\n",
    "\n",
    "# Parse\n",
    "big_sample_df['predicted_label'] = big_sample_df['llm_response'].apply(parse_response)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "58dae77e",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Map 'PASS' to 0 and 'FAIL' to 1\n",
    "label_mapping = {'PASS': 0, 'FAIL': 1}\n",
    "big_sample_df['true_label'] = big_sample_df['Target'].map(label_mapping)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "dc9cbe0b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Accuracy: 0.5893\n",
      "Precision: 0.8571\n",
      "Recall: 0.5581\n",
      "F1 Score: 0.6761\n"
     ]
    }
   ],
   "source": [
    "from sklearn.metrics import accuracy_score, precision_score, recall_score, f1_score\n",
    "\n",
    "# Filter only valid predictions\n",
    "valid_big_df = big_sample_df[big_sample_df['predicted_label'] != -1]\n",
    "\n",
    "accuracy = accuracy_score(valid_big_df['true_label'], valid_big_df['predicted_label'])\n",
    "precision = precision_score(valid_big_df['true_label'], valid_big_df['predicted_label'])\n",
    "recall = recall_score(valid_big_df['true_label'], valid_big_df['predicted_label'])\n",
    "f1 = f1_score(valid_big_df['true_label'], valid_big_df['predicted_label'])\n",
    "\n",
    "print(f\"Accuracy: {accuracy:.4f}\")\n",
    "print(f\"Precision: {precision:.4f}\")\n",
    "print(f\"Recall: {recall:.4f}\")\n",
    "print(f\"F1 Score: {f1:.4f}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "eae1a97e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting wordcloud\n",
      "  Downloading wordcloud-1.9.4-cp312-cp312-win_amd64.whl.metadata (3.5 kB)\n",
      "Requirement already satisfied: numpy>=1.6.1 in .\\.venv\\lib\\site-packages (from wordcloud) (1.26.4)\n",
      "Collecting pillow (from wordcloud)\n",
      "  Using cached pillow-11.2.1-cp312-cp312-win_amd64.whl.metadata (9.1 kB)\n",
      "Collecting matplotlib (from wordcloud)\n",
      "  Using cached matplotlib-3.10.3-cp312-cp312-win_amd64.whl.metadata (11 kB)\n",
      "Collecting contourpy>=1.0.1 (from matplotlib->wordcloud)\n",
      "  Using cached contourpy-1.3.2-cp312-cp312-win_amd64.whl.metadata (5.5 kB)\n",
      "Collecting cycler>=0.10 (from matplotlib->wordcloud)\n",
      "  Using cached cycler-0.12.1-py3-none-any.whl.metadata (3.8 kB)\n",
      "Collecting fonttools>=4.22.0 (from matplotlib->wordcloud)\n",
      "  Downloading fonttools-4.58.1-cp312-cp312-win_amd64.whl.metadata (108 kB)\n",
      "Collecting kiwisolver>=1.3.1 (from matplotlib->wordcloud)\n",
      "  Using cached kiwisolver-1.4.8-cp312-cp312-win_amd64.whl.metadata (6.3 kB)\n",
      "Requirement already satisfied: packaging>=20.0 in .\\.venv\\lib\\site-packages (from matplotlib->wordcloud) (24.1)\n",
      "Collecting pyparsing>=2.3.1 (from matplotlib->wordcloud)\n",
      "  Using cached pyparsing-3.2.3-py3-none-any.whl.metadata (5.0 kB)\n",
      "Requirement already satisfied: python-dateutil>=2.7 in .\\.venv\\lib\\site-packages (from matplotlib->wordcloud) (2.9.0.post0)\n",
      "Requirement already satisfied: six>=1.5 in .\\.venv\\lib\\site-packages (from python-dateutil>=2.7->matplotlib->wordcloud) (1.16.0)\n",
      "Downloading wordcloud-1.9.4-cp312-cp312-win_amd64.whl (301 kB)\n",
      "Using cached matplotlib-3.10.3-cp312-cp312-win_amd64.whl (8.1 MB)\n",
      "Using cached pillow-11.2.1-cp312-cp312-win_amd64.whl (2.7 MB)\n",
      "Using cached contourpy-1.3.2-cp312-cp312-win_amd64.whl (223 kB)\n",
      "Using cached cycler-0.12.1-py3-none-any.whl (8.3 kB)\n",
      "Downloading fonttools-4.58.1-cp312-cp312-win_amd64.whl (2.2 MB)\n",
      "   ---------------------------------------- 0.0/2.2 MB ? eta -:--:--\n",
      "   ---------------------------------------- 2.2/2.2 MB 25.2 MB/s eta 0:00:00\n",
      "Using cached kiwisolver-1.4.8-cp312-cp312-win_amd64.whl (71 kB)\n",
      "Using cached pyparsing-3.2.3-py3-none-any.whl (111 kB)\n",
      "Installing collected packages: pyparsing, pillow, kiwisolver, fonttools, cycler, contourpy, matplotlib, wordcloud\n",
      "Successfully installed contourpy-1.3.2 cycler-0.12.1 fonttools-4.58.1 kiwisolver-1.4.8 matplotlib-3.10.3 pillow-11.2.1 pyparsing-3.2.3 wordcloud-1.9.4\n",
      "Note: you may need to restart the kernel to use updated packages.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n",
      "[notice] A new release of pip is available: 24.2 -> 25.1.1\n",
      "[notice] To update, run: python.exe -m pip install --upgrade pip\n"
     ]
    }
   ],
   "source": [
    "pip install wordcloud"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "d3386e40",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x750 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from wordcloud import WordCloud\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Only take trials where true label is FAIL (1)\n",
    "failed_trials = big_sample_df[big_sample_df['true_label'] == 1]\n",
    "\n",
    "# Combine all brief summaries\n",
    "text = \" \".join(failed_trials['Brief Summary'].dropna())\n",
    "\n",
    "# Generate WordCloud\n",
    "wordcloud = WordCloud(width=800, height=400, background_color='white').generate(text)\n",
    "\n",
    "plt.figure(figsize=(15, 7.5))\n",
    "plt.imshow(wordcloud, interpolation='bilinear')\n",
    "plt.axis('off')\n",
    "plt.title('WordCloud for Failed Trials', fontsize=20)\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "436ef63a",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
